willdate
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with ...
ACC 2023: MitraClip meets endpoints at five years in COAPT trial
Final, five-year clinical outcomes from the COAPT trial, evaluating transcatheter mitral valve r...
ACC 2023: Benefit of TAVI “consistent” over first three years in low risk patients
Three-year results from the Evolut Low Risk trial have shown “durable” benefits of transcatheter...
ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial
Hotly-anticipated results of the randomised TRILUMINATE pivotal trial, presented during the 2023...
Preclinical model could aid future research of NSTEMI therapies
Researchers have detailed a new preclinical model for non-ST elevation myocardial infarction (NSTEMI...
HyperVue intracoronary imaging system gains US FDA approval
SpectraWAVE has announced US Food and Drug Administration (FDA) 510(k) clearance of its flagship int...
CRT 2023: Abbott shares new data on Navitor TAVI and Amplatzer Amulet LAAO systems
Results from the PORTICO NG study of Abbott’s Navitor transcatheter aortic valve implantation (TAVI)...
Five-year durability analysis of CoreValve and Evolut platforms “underscores long-term promise of TAVI”
Five-year bioprosthetic valve dysfunction data for Medtronic’s CoreValve and later-generation Ev...
Results of cell therapy trial in patients with heart failure due to low EF published in JACC
Results of a trial involving cell therapy in patients with chronic heart failure due to low ejec...
CONFORMAL EFS study results presented at CRT 2023
Results from the CONFORMAL early feasibility study (EFS), evaluating the use of angiography comp...
Risk model adds to prediction tools for surgical risk in adult congenital heart disease patients
A model designed to predict surgical risk in the setting of adult congenital heart disease (ACHD) im...
Medtronic welcomes ESC and EAPCI renal denervation consensus statement
Medtronic has welcomed the publication of the consensus statement on renal denervation issued by the...
First patient treated in A PRIORI pilot trial of Aortix circulatory support device
Procyrion has announced the successful treatment of the first patients in the A PRIORI—Aortix therap...
Medtronic relaunches Harmony transcatheter pulmonary valve
Medtronic has announced the relaunch of its Harmony transcatheter pulmonary valve (TPV) system, a mi...
Barostim misses primary endpoint in BEAT-HF postmarket trial
CVRx has announced the preliminary topline results of the BeAT-HF—Baroreflex activation therapy for ...
US FDA clears tool to rapidly analyse RV/LV ratio
RapidAI announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid R...
Renal denervation “can reach new shores”
The publication of a consensus statement from the European Society of Cardiology (ESC) Council o...
Teleflex grows catheter portfolio following US FDA approval
Teleflex Incorporated has today announced key milestones in the release of two new catheters, includ...
Xeltis secures funding to progress clinical trials
Xeltis has raised €32 million in a Series D2 equity fundraise, backed by a syndicate of current and ...
ACC, AHA and SCAI lay roadmap for interventional cardiology training
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Society for C...
ESC and EAPCI publish renal denervation consensus statement
Renal denervation represents another treatment option in patients with uncontrolled resistant hypert...
COPS trial shows feasibility of using a cutting balloon at high pressure to modify calcium prior to PCI
Attendees of the 2023 Joint Interventional Meeting (JIM, 9–11 February, Milan, Italy) heard results ...
OPN NC “super-high-pressure” coronary balloon launches in USA
SIS Medical AG has announced the launch of its OPN NC percutaneous transluminal coronary angioplasty...
GE HealthCare to acquire AI ultrasound developer Caption Health
GE HealthCare has signed an agreement to acquire Caption Health, a developer of artificial intel...
ADVERTORIAL: DCB therapy offers a glimpse of interventional cardiology’s past and future
This advertorial is sponsored by Cardionovum
“Everything started with balloon inflations in t...
Home-based therapy can help to reduce anxiety and depression in cardiovascular patients
A randomised study led by Greater Manchester Mental Health NHS Foundation Trust (GMMH) and the U...
Cardiovascular News 68 – February 2023: US Edition
In this issue:
Medicare study reopens guideline debate around surgery and PCI in patients with ...
Cardiovascular News 68 – February 2023: OUS Edition
In this issue:
Medicare study reopens guideline debate around surgery and PCI in patients with ...
ADVERTORIAL: A step forward in scoring balloon catheter design
This advertorial is sponsored by iVascular
A new coronary scoring balloon dilatation catheter...
Automated alert tool “associated with a small decrease in contrast use” during PCI
Performance improvement company Biome Analytics has announced the publication of a study in Circulat...
TruLeaf Medical to trial “two-stage” TMVR platform
TruLeaf Medical is to conduct a first-in-human clinical trial of a “two-stage” transcatheter mit...
PCI can be performed as safely without on-site access to surgery, says SCAI
Percutaneous coronary intervention (PCI) without on-site surgical support is as safe as PCI at centr...
Cardiovascular-aortic community comes together at CX 2023
From cutting-edge aortic interventions to consensus on revascularisation strategies in the periphera...
ADVERTORIAL: A wealth of data underscore treatment choices for coronary DCBs
This advertorial is sponsored by B. Braun Melsungen AG
The modern field of percutaneous coron...
First patient treated in LeAAPS trial of left atrial appendage occlusion in cardiac surgery patients
AtriCure has announced that the first patient was treated in the LeAAPS clinical trial, a prospectiv...
Slow progress made on gender balance in cardiovascular trial leadership
Little progress has been made over the last decade in improving gender balance in leadership positio...
Nieves Gonzalo
Interventional cardiology is a rapidly evolving field, offering the opportunity to learn procedures ...
Medicare study reopens guideline debate around surgery and PCI in patients with multivessel coronary artery disease
An analysis of data from more than 100,000 patients with multivessel coronary artery disease und...
First US patient enrolled into study of Selution SLR coronary drug-eluting balloon
The first US patient has been enrolled at Medstar Washington Hospital Center (Washington DC, USA) in...
STS 2023: Risk assessment tool “sets a high bar” when considering alternatives to surgery in mitral valve repair
A new risk assessment tool has been produced to provide a comprehensive method for assessing ope...
Enrolment milestone reached in trial of angiography-based vessel fractional flow reserve in coronary revascularisation
Pie Medical Imaging has announced the enrolment of the 500th patient in the FAST III clinical trial,...
Trial of super saturated oxygen therapy after PCI begins enrolment
Zoll has announced that the first patient has been enrolled in the REAL SSO2 post-market observation...
Registry data point to a declining rate of complications among primary MR patients
The largest dedicated registry on mitral transcatheter edge-to-edge repair (M-TEER) in primary m...
Shockwave agrees to acquire Neovasc
Shockwave Medical has entered into a definitive agreement to acquire Neovasc Inc, developer of t...
US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients
The US Food and Drug Administration (FDA) has approved the Navitor (Abbott) transcatheter aortic val...
Effects of short DAPT “consistent regardless of high bleeding risk and complex PCI”
Research evaluating the effects of high bleeding risk (HBR) and complex percutaneous coronary interv...
Pie Medical Imaging announces launch of CAAS Qardia 2.0 echocardiography software platform
Pie Medical Imaging has launched a new version of its echocardiography software platform—CAAS Qardia...
NICE lowers threshold for statins to prevent cardiovascular events
The UK’s National Institute for Health and Care Excellence (NICE) has published draft guidance recom...
HVR Cardio closes €10.7 million series B funding round
HVR Cardio has closed on a €10.7 million series B round of financing. The Series B Round was led...
Depression increases likelihood of non-adherence to medical therapy post-PCI
Patients with depression were 10–20% less likely to adhere to guideline-directed medical therapy aft...
Multidisciplinary teams at the heart of new guidelines on aortic disease management
Closer ties between cardiologists, cardiac surgeons and vascular surgeons will be a hallmark of the ...
MedAlliance’s Selution SLR receives coronary de novo IDE approval
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional US Food and Dr...
Preclinical study outlines key features of foam-based LAA closure device
A preclinical study demonstrating key features of the foam-based left atrial appendage closure d...
Cardiac Dimensions closes funding round to support US EMPOWER pivotal study
Cardiac Dimensions has closed a US$35 million Series D financing round. The financing was co-led...
Funding secured to advance development of Pulse IVL system
AVS has announced that it raised US$20 million in Series B financing, which the company says will ac...
Cardiovascular News’ top stories of 2022
Which stories, features and interviews captured the attention of the cardiovascular community across...
SCAI announces recipients of early career grant scheme
The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the four recipie...
No sex difference seen in outcomes for transcatheter tricuspid valve intervention
Transcatheter tricuspid valve intervention is associated with similar outcomes in both women and...
ReCor appoints Lara Barghout to lead commercialisation of Paradise renal denervation system
ReCor Medical and its parent company Otsuka Medical Devices have announced the appointment of La...
Enrolment begins in trial to assess new therapy in patients deemed unsuitable for anticoagulants
Anthos Therapeutics has announced that it has enrolled the first patient in LILAC-TIMI 76, a pha...
Johnson & Johnson completes Abiomed acquisition
Johnson & Johnson has today announced it has completed its acquisition of Abiomed. Abiomed is no...
Machine learning enables “clinically important” characterisation of coronary artery disease
Using machine learning and clinical data from electronic health records, researchers have constructe...
Stem cell plasters “could revolutionise treatment of congenital heart disease”
Researchers have developed ‘stem cell plasters’ which it is hoped will revolutionise the way sur...
Enrolment begins in Impella ECP pivotal trial after US FDA green light
The first two patients have been enrolled in the Impella ECP pivotal trial, after the US Food an...
STAR-T trial of antithrombotic removal system during cardiac surgery to continue
CytoSorbents Corporation has received the recommendation from the independent Data and Safety Mo...
First US procedure performed using ShortCut leaflet splitting device
Pi-Cardia has announced that the first patient in the USA has been successfully treated with ShortCu...
Cardiology societies urge rethink of randomised controlled trial design
The current model for randomised clinical trials must be redesigned for the modern age, according to...
Pilot study of wire pacing sleeve yields positive results in TAVI and PCI procedures
A first-in-human trial using a purpose-built device to provide direct wire pacing without the need f...
Corindus rebrands to Siemens Healthineers Endovascular Robotics
Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedi...
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the tran...
UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction
AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...
TRICares secures financing to fund development of Topaz tricuspid valve replacement system
TRiCares has announce the second closing and completion of its Series C financing round, successfull...
First patient randomised in RESPONDER-HF trial of Corvia atrial shunt
Corvia Medical has announced that the first patient has been randomised in RESPONDER-HF, a globa...
ESC warns of cardiac device shortage due to implementation of MDR regulations in Europe
The European Society of Cardiology (ESC) has urged European Union (EU) health ministers to act to pr...
Postmarket data point to lower rates of PVL with Acurate neo2 TAVI valve
The addition of an annular sealing skirt, among other design changes in the Acurate neo2 transca...
TRISCEND trial reports one-year outcomes in patients undergoing transcatheter tricuspid valve implantation
One-year results from the TRISCEND study, investigating the Evoque (Edwards Lifesciences) tricus...
ADVERTORIAL: TAVI valve durability and reliability: How patient lifetime management is evolving
This advertorial is sponsored by Medtronic
Durability, reliability, accuracy. These are just ...
DurAVR heart valve system gets green light from US FDA for early feasibility study
Anteris Technologies has announced that the US Food and Drug Administration (FDA) has conditionally ...
First implant of MonarQ tricuspid valve replacement system performed in Copenhagen
inQB8 Medical Technologies, in partnership with Peijia Medical, has announced first successful i...
Nyra Medical secures investment for transcatheter mitral valve repair technology
Nyra Medical has announced the closing of a US$20 million Series A financing.
The round was c...
First-in-human procedure performed using Impella RP Flex
The first implant procedure using the Impella RP Flex (Abiomed) percutaneous pump, following its rec...
Late-breaking Xlimit randomised trial data shared at CSC 2022 congress
Data presented at an innovation session at the 2022 Structural and Coronary Intervention Course (CS...
Timothy D Henry
A pioneer of one of the first regional ST-segment elevation myocardial infarction (STEMI) systems in...
Carmat resumes commercial implants of Aeson artificial heart
Carmat has announced the resumption of commercial implants of its Aeson total artificial heart.
C...
CroíValve reports successful first in human implants of its Duo tricuspid coaptation valve system
CroíValve has announced the successful first in human implants of its Duo tricuspid coaptation v...
Cardiovascular News 67 – November 2022: OUS Edition
In this issue:
Latest evidence from key renal denervation trials
REVIVED-BCIS 2: PCI fails t...
Cardiovascular News 67 – November 2022: US Edition
In this issue:
Latest evidence from key renal denervation trials
REVIVED-BCIS 2: PCI fails t...
Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND
Extended follow-up of the ISCHEMIA-EXTEND trial has shown no difference in rates of all-cause mo...
AI system to aid decision making for aortic aneurysm treatment
Viz.ai has announced a partnership with Illuminate, a developer of proprietary natural language proc...
Use of clinical support platform “reduces risk of kidney injury” from PCI
Patients at high risk for acute kidney injury (AKI), the most common complication of percutaneous co...
RELIEF clinical study to assess use of Cardioform septal occluder for migraine relief
WL Gore & Associates has announced that it is initiating the RELIEF clinical study—an invest...
Neovasc Reducer assigned outpatient reimbursement code from CMS
Neovasc has announced that the Centers for Medicare and Medicaid Services (CMS) has assigned the Neo...
New surgical thresholds and need for multidisciplinary teams reflected in revised aortic guidelines
The American College of Cardiology (ACC) and American Heart Association (AHA) have jointly published...
Johnson & Johnson reaches agreement to acquire Abiomed
Johnson & Johnson is to acquire Abiomed, it was announced today, after the two organisations ent...
Impella RP Flex with SmartAssist receives US FDA approval to treat right heart failure
Abiomed has announced that Impella RP Flex with SmartAssist has received US Food and Drug Administra...
Carmat gains approval to resume clinical study of total artificial heart
Carmat, developer of the Aeson total artificial heart, has announced that it has been granted th...
US FDA accepts post-approval study reports for Impella
Abiomed has announced the US Food and Drug Administration (FDA) has accepted and closed the post...
First patients treated in SAFE-TAVI clinical study
OpSens Medical has announced the successful completion of the first cases in a clinical study—SAFE-T...
Selution SLR receives US FDA investigational device exemption approval for coronary clinical trial
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received US Food and Drug Administr...
Ticagrelor after CABG associated with a decreased risk of vein graft failure compared to aspirin
In patients undergoing coronary artery bypass graft (CABG) surgery, the addition of ticagrelor t...
LeAAPS trial to explore benefit of left atrial appendage occlusion in cardiac surgery patients at risk for stroke
Researchers are to investigate the safety and efficacy of performing left atrial appendage occlu...
AccurKardia and Mawi link up to add automated ECG analytics for the new Mawi Watch
AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocard...
HeartFlow receives US FDA approval for Plaque and RoadMap analysis AI products
HeartFlow has received US Food and Drug Administration (FDA) 510(k) clearance on two new, AI-pow...
MedAlliance to be acquired by Cordis
MedAlliance is to be acquired by Cordis, it was announced today, after the two companies reached agr...
Rates of stroke and embolism lower with apixaban compared to rivaroxaban
In a large, population-based study of patients with atrial fibrillation (AF) and valvular heart dise...
Abiomed gains FDA approval for Impella low profile sheath
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed to market a ne...
Swedish registry data point to survival benefit for younger patients undergoing CABG
An analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) has s...
Analysis shows survival benefit in high-risk PCI supported by Impella
An analysis of more than 2,000 patients from a large US real-world database finds that patients ...
Swedish and Dutch organisations agree to research collaboration
The Uppsala Clinical Research Center (UCR) and the European Cardiovascular Research Institute (E...
Minimally invasive aortic perfusion cannula receives EACTS Techno-College innovation award
The developers of a cannula for minimally-invasive central aortic perfusion—MIC-Cannula—received...
CathWorks gains Japanese regulatory approval for FFRangio system
CathWorks has announced approval of the fourth generation CathWorks FFRangio system by the Japan...
EACTS 2022: Global studies will fill gap for “high-quality evidence” on invasive treatment of ischaemic cardiomyopathy
A global research initiative will compare coronary artery bypass graft surgery (CABG) and percut...
EACTS 2022: “Wake up call” for trialists over gender balance
Clinical trials in cardiothoracic surgery must ensure that sufficient numbers of women are enrol...
Latest data underscore optimism for future of renal denervation
Ajay Kirtane (Columbia University Irving Medical Center New York-Presbyterian Hospital, New York...
Long-term P2Y12 monotherapy after PCI “may be a promising strategy”
Three-year outcomes from the SMART-CHOICE trial have shown that P2Y12 inhibitor monotherapy was asso...
Enrolment completed in trial comparing PCI in diabetic patients
ABILITY DIABETES-GLOBAL, a randomised controlled head-to-head trial comparing safety and efficacy of...
Puzzle Medical wins 2022 TCT Shark Tank innovation competition
Puzzle Medical Devices was announced as the winner of the Shark Tank innovation competition at the 2...
Rivaroxaban may be an option for reducing radial artery occlusion in transradial coronary procedures
The use of rivaroxaban for seven days after a transradial coronary procedure reduced the rate of...
Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients
Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To...
First US TAVI procedure performed using SavvyWire guidewire
OpSens has announced that Philippe Genereux (Morristown Medical Center, Morristown, USA) has perform...
Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022
Biotronik has announced the presentation of new full-cohort two-year BIOSOLVE-IV data. In a post...
FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI
Medtronic has received Food and Drug Administration (FDA) approval for the treatment of non-left mai...
Clinical trial of TAVI in severe aortic regurgitation completes enrolment
JenaValve Technology has announced the successful completion of patient enrolment in the ALIGN-AR Pi...
TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation
Analysis of data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) ...
TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures
Results from a multicentre randomised trial comparing ultrasound with fluoroscopic guidance vers...
Medtronic expands US rollout of Evolut FX TAVI system
Medtronic has announced the expanded US market release of its newest-generation, self-expanding tran...
Shockwave initiates all female coronary IVL registry study
Shockwave Medical has initiated a prospective coronary intervention study consisting of all female p...
Breakthrough device designation granted for SirPlux Duo coronary DCB in small vessels
Advanced NanoTherapies has been granted US Food and Drug Administration (FDA) breakthrough devic...
TCT 2022: Amulet occluder keeps pace with Watchman at three years
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) receiving the Amplatz...
TCT 2022 hears “important data” from renal denervation trials
Findings from the RADIANCE II randomised pivotal trial, presented at the 2022 Transcatheter Card...
TCT 2022: Valentin Fuster receives career achievement award
The major contribution of Valentin Fuster (Mount Sinai Health System, New York, USA) to the fiel...
TCT 2022: Pascal non-inferior to MitraClip in head-to-head trial in degenerative MR patients
The first randomised trial to compare two transcatheter edge-to-edge repair (TEER) devices —CLAS...
TCT 2022: No difference in rates of post-TAVI stroke seen with cerebral embolic protection device in PROTECTED TAVR
Among patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) the use of...
US FDA grants 510(k) clearance for SavvyWire TAVI guidewire
OpSens has received 510(k) regulatory clearance from the US Food & Drug Administration (FDA) for...
Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser
The 2022 Transcatheter Cardiovascular Therapeutics (TCT, 16–19 September, Boston, USA) opened wi...
Abiomed given green light for RECOVER IV randomised trial
Abiomed has announced two approvals from the US Food and Drug Administration (FDA) related to clinic...
Cardiac Implants announces successful adjustment procedure using its Tri-Ring device to treat TR
Cardiac Implants has announced the successful initial deployment of its annuloplasty ring with imple...
Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB
Concept Medical has announced the successful completion of the TRANSFORM 1 RCT. The randomised c...
TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude
A budget impact analysis comparing transcatheter aortic valve implantation (TAVI) with surgical ...
Vascade vascular and venous closure devices gain CE mark
Haemonetics Corporation has received CE mark certification for its Vascade vascular closure and ...
Latest Sapien TAVI valve features anti-calcification technology
Edwards Lifesciences has announced the launch of the Sapien 3 Ultra Resilia valve—combining Edwards’...
Three-year data “reinforce safety and efficacy” of Abbott’s Amplatzer Piccolo in infants with PDA
Abbott has announced three-year data for its Amplatzer Piccolo occluder for the treatment of patent ...
The time for change is now: Call for action over “ageing and unbalanced” cardiothoracic surgery community
Analysis of the global make-up of the four largest global societies for cardiothoracic surgery sugge...
Results of cuffless blood pressure monitor presented at AHA Hypertension Sessions
Results of an analysis of Aktiia’s cuffless blood pressure (BP) monitoring system are being presente...
First patient joins study of SSO2 therapy post-PCI
Zoll Medical has announced that the first patient has been enrolled in the AMIHOT III post-approval ...
Abbott’s Amplatzer Talisman PFO occlusion system launched in Europe
Abbott has announced the European launch of its Amplatzer Talisman patent foramen ovale (PFO) occlus...
AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal AF
AtriAN Medical has announced that it has completed enrolment of a second study using its selective p...
Tom Nguyen
As a proponent of minimally invasive cardiac surgery and transcatheter techniques, Tom Nguyen (Unive...
Cardiovascular News’ top 10 most popular stories of August 2022
The most read stories from across Cardiovascular News in August 2022 include highlights from the Eur...
FDA clears Viz.ai’s right-to-left ventricle ratio algorithm
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for an automated right ve...
Latest centre begins using Philips’ Verisight Pro 3D intracardiac echocardiography catheter
Royal Philips has announced that Baptist Health’s Miami Cardiac & Vascular Institute (Miami, USA...
New DAPT labelling approved for Watchman FLX device
Boston Scientific has received US Food and Drug Administration (FDA) approval to expand the inst...
First patient enrolled in Hyper II study evaluating hybrid approach in long diffuse CAD
Cardionovum has announced the enrolment of the first patient in the international Hyper II clini...
JenaValve raises US$100 Million to advance Trilogy TAVI system
JenaValve Technology has announced that it has completed the initial closing of a US$100 million Ser...
ESC 2022: Risk score predicts mortality for AF patients after TAVI
Researchers have developed a risk score to predict mortality for patients with atrial fibrillati...
ESC 2022: Survival benefit seen following use of Abbott’s HeartMate 3 LVAD
Abbott has announced the release of late-breaking showing that its HeartMate 3 heart pump extend...
ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures
Transradial access for percutaneous coronary procedures is associated with lower rates of all-ca...
ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI
Fifteen-month results from the MASTER DAPT trial have shown that the preserved ischaemic benefit...
ESC 2022: Kidney disease patients with coronary disease see no improvement in survival at five years with an invasive approach
In patients with advanced chronic kidney disease (CKD) and chronic coronary disease, an invasive...
ESC 2022: FRAME-AMI sheds light on best strategy for selecting non-infarct lesions for PCI
Selection of non-infarct related artery (IRA) lesions for intervention using fractional flow res...
ESC 2022: High-risk aortic stenosis could be picked up using AI
Late-breaking research presented at the European Society of Cardiology (ESC) annual congress (26...
ESC 2022: POST-PCI trial finds no benefit to routine functional testing in high-risk PCI patients
Among high-risk patients undergoing percutaneous coronary intervention (PCI), a follow-up strate...
ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT
Results of one of the first and only randomised, blinded trials to assess the use of an artifici...
ESC 2022: REVIVED data show PCI does not benefit patients with severe left ventricular dysfunction
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ho...
ESC 2022: SECURE trial finds “polypill” results in lower risk of cardiovascular events compared to usual care
Use of a ‘polypill’ after myocardial infarction (MI)—an all-in-one pill containing an antiplatel...
ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes
The timing of dosing of antihypertensive medication—whether it is taken in the morning or in the...
Programme released for TCT MedTech Innovation Forum
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the programme...
Medtronic launches Onyx Frontier coronary stent following CE mark approval
Medtronic has announced the launch of its latest generation drug-eluting coronary stent—Onyx Frontie...
Cardiovascular News 66 – August 2022: OUS Edition
In this issue:
Call for action over age and gender profile of global cardiothoracic surgery com...
Cardiovascular News 66 – August 2022: US Edition
In this issue:
Call for action over age and gender profile of global cardiothoracic surgery com...
Miracor’s PiCSO technology approved by FDA for investigational device exemption study
Miracor Medical has announced the approval of an investigational device exemption (IDE) from the...
First-in-human procedure completed using ShortCut Mitral device
Pi-Cardia has announced a successful first-in-human treatment of the mitral valve with the ShortCut ...
Edwards gains CE mark for Pascal Precision system for mitral and tricuspid regurgitation
Edwards Lifesciences has announced that the company's Pascal Precision transcatheter valve repai...
Restore EF study “shows heart function, symptom improvements” for high-risk PCI patients supported by Impella
Abiomed has announced the results of the Restore EF study, demonstrating that Impella-supported hig...
CX Aortic Vienna: Cardiac and vascular surgeons collaborate at the vanguard of aortic care
CX Aortic Vienna returns in October for its third edition (24–26 October, Digital), bringing togethe...
AHA and CRF announce collaborative education programme
The American Heart Association (Association) and the Cardiovascular Research Foundation (CRF) have a...
Spotlight turns to TAVI in patients with moderate aortic stenosis
Ongoing clinical trials looking at transcatheter aortic valve implantation (TAVI) for patients w...
Cardiovascular News’ top 10 most popular stories of July 2022
The most read stories from across Cardiovascular News in July 2022 include reflections on the future...
“Worrisome” rise in cardiovascular disease predicted out to 2060
Projected rates of cardiovascular risk factors and disease will increase significantly in the USA by...
“Positive” 30-day outcomes for patients receiving Optimum transcatheter aortic valve
Thubrikar Aortic Valve has announced successful 30-day outcomes in the first two patients receiving ...
Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine
Cardiac surgeons from North America, Europe and Latin America are among the signatories to a multidi...
Genetic “cure” for cardiomyopathy is selected as winner of Big Beat Challenge
A project to develop genetic therapies to effectively cure cardiomyopathy has been announced as ...
Three-year results of RANGO registry presented at EuroPCR
iVascular has announced the release of three-year observational data concerning its Angiolite cobalt...
Neovasc gains approval for protocol supplement to COSIRA-II trial
Neovasc has announced that the US Food and Drug Administration (FDA) has approved a protocol sup...
Digital drainage system for cardiac surgery “safe and effective”
Centese has announced the publication of the first peer-reviewed clinical study of its Thoraguard di...
Pi-Cardia gains FDA nod for study of ShortCut leaflet splitting device
Pi-Cardia has received Investigational Device Exemption (IDE) approval from the US Food and Drug Adm...
Ultrasound renal denervation meets primary efficacy endpoint in RADIANCE II study
ReCor Medical and Otsuka Medical Devices have announced that the RADIANCE II US Food and Drug Admini...
Steps needed to include disadvantaged patients in mitral and tricuspid trials
Incentives for the enrolment of patients from socieconomically disadvantaged groups, as well as ...
Cathbot completes enrolment in clinical study of robotic-assisted PCI in China
Cathbot—a joint venture between Robocath and MicroPort—has enrolled the last patient in its clinical...
Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI
Preventing coronary obstruction after transcatheter aortic valve implantation (TAVI) becomes inc...
New funding for research to examine use of blood pressure cuffs for heart failure patients with pacemakers
A research project at the University of Leeds (Leeds, UK) aiming to find an easier way to establ...
FDA grants breakthrough status for Accucinch ventricular restoration system
Ancora Heart has announced that the US Food and Drug Administration (FDA) has granted Breakthrou...
First patients enrolled in study of Booster spiral balloon therapy for acute myocardial infarction
Intratech Medical has announced the successful enrolment of two patients in a multicentre first-in-h...
VenusP-Valve gains approval from China’s NMPA
The VenusP-Valve (Venus Medtech) transcatheter pulmonic valve replacement (TPVR) system has been...
Stress testing can guide patient selection for coronary revascularisation
Patients identified by nuclear stress testing as having severe stress-induced myocardial ischaem...
Echocardiographers face “under-recognised” radiation exposure risk in the cath lab
Echocardiographers may be at significantly greater risk of exposure to radiation than interventional...
TCT MedTech Innovation Forum to spotlight opportunities for innovation
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the launch of the...
Analysis shows “positive trend” with thinner strut stents in patients with small vessels
A subgroup analysis of the BIO-RESORT trial has shown a “trend towards better outcomes” with thi...
HeartBeam expands software platform to cover unstable angina
HeartBeam is expanding the available patient population for its emergency department software techno...
Cardiovascular News’ top 10 most popular news stories of June 2022
The most read stories from across Cardiovascular News in June 2022 include highlights from TVT 2022 ...
Female representation in interventional cardiology remains low, but there is cause for hope
Suzanne Baron and Ki Park detail some of the barriers facing women in the field of interventiona...
Advanced NanoTherapies closes Series A funding round
Advanced NanoTherapies has closed a US$7.2 million Series A equity financing round marking a tot...
EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients
Results from the first commercial implants of the Trilogy transcatheter aortic valve implantatio...
First patients enrolled in Manta Ultra vascular closure device study
Teleflex has announced the first patient enrolment in a clinical study that is intended to demon...
AF after surgery is linked to an increased risk of heart failure hospitalisation
People who develop an arrhythmia after surgery have an increased risk of subsequently being admitted...
Acutus launches expanded suite of left-heart access products
Acutus Medical has announced the commercial launch of an expanded suite of left-heart access pro...
CABG “associated with favourable outcomes and increased long-term survival” among octogenarians
A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochester, USA) has found t...
CONFORM pivotal trial of CLAAS system begins enrolment
Conformal Medical has announced the launch of the CONFORM pivotal trial with the enrolment of th...
TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens
Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO) using the Watchman...
TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device
Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston Scientific) device ...
TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria
Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip treatment in secondar...
TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”
Data from the first report on patients with a pacemaker lead across the tricuspid valve have sho...
First patient treated in HEAL-IST clinical trial
AtriCure has announced that the first patient has been treated in the HEAL-IST trial, evaluating the...
Patients with mitral annulus calcification at higher risk of mitral valve dysfunction
A retrospective review of more than 24,000 patients who underwent an electrocardiogram (ECG) has fou...
First-in-human results of Captis embolic protection device presented at EuroPCR 2022
Filterlex Medical has announced results from a first-in-human (FIH) study demonstrating the safe...
Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care
A study has revealed the “global collateral damage” caused by the disruption to cardiac services cau...
UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year
Transcatheter aortic valve implantation (TAVI) was found to be non-inferior to surgery for all-c...
EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies
The use of distal radial artery access for percutaneous coronary intervention (PCI) comes at the...
AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure
Concurrent tricuspid valve surgery and left ventricular assist device (LVAD) implantation did n...
SCAI 2022: Analysis looks at coronary IVL outcomes in women and men
New data confirming one-year outcomes with coronary intravascular lithotripsy (IVL, Shockwave Me...
SCAI names Sunil Rao as incoming president
Sunil Rao (Duke University Health System, Durham, USA) has assumed the office of president of th...
Cordella meets safety and efficacy endpoints in SIRONA 2 clinical trial
Endotronix has announced data from the SIRONA 2 clinical trial evaluating safety and efficacy of...
EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study
One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Edwards Lifesciences) ...
EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique
Use of the cusp overlap technique for the deployment of devices in transcatheter aortic valve im...
EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety
Results of the 20-patient, first-in-human clinical study supporting the safety and efficacy of the S...
EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed
Patients in England with ST-elevation myocardial infarction (STEMI) had an average loss of 1.86 ...
SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”
Analysis of data from a US-wide health system suggests that the volume of percutaneous coronary inte...
Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022
Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, France) focused on th...
EuroPCR 2022 hears new data on robotic PCI
New data on robotic-assisted percutaneous coronary intervention (PCI) have been presented during a l...
EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity
Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR 2022 (17–20 May, Pa...
EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension
Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France) underscore the pot...
Medtronic gains FDA approval for Onyx Frontier drug-eluting stent
Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for the ...
Cardiovascular News 65 – May 2022: US Edition
In this issue:
New data hint at positive performance of TAVI on structural valve durability
...
Cardiovascular News 65 – May 2022: OUS Edition
In this issue:
New data hint at positive performance of TAVI on structural valve durability
...
Analysis charts “significant” growth of US TEER procedures since 2012
A US analysis comparing trends in transcatheter and surgical mitral valve repair (SMVR) has found a ...
Abbott funds programme to boost diversity in clinical trial leadership
Abbott has announced a new partnership with Women as One to launch a new programme designed to train...
Vijay Kunadian
Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastl...
ADVERTORIAL: Cath lab technologies for medicine in the precision age
This advertorial is sponsored by Siemens Healthineers
In the modern cath lab, having a suite of t...
ADVERTORIAL: TAVI valve durability under the microscope
This advertorial is sponsored by Medtronic
Due to the growth of transcatheter aortic valve im...
Cardiovascular News’ top 10 most popular stories of April 2022
The most read stories from across Cardiovascular News in April 2022 include highlights and late-brea...
DCB in PCI: Adjunctive therapy or standard of care?
This educational supplement, sponsored by Medtronic, explores the science underpinning the use of dr...
“TAVI was my baby, now it is a teenager”
In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 is a landmark date, ...
Health Canada approval granted for SavvyWire TAVI guidewire
OpSens has announced that it has received Health Canada approval for the SavvyWire, its new guidewir...
Japanese and US regulatory approvals granted for BioFreedom stent
Biosensors International Group has announced both the Japanese Pharmaceuticals and Medical Devic...
First patient enrolled in EXPAND TAVR II trial
Medtronic has announced the first patient enrolment in the EXPAND TAVR II pivotal trial, the fir...
SCAI issues position paper on transaxillary arterial access
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...
Translumina announces launch of dual drug polymer-free coated stent
Translumina has announced the launch of Vivo Isar, its latest generation dual drug polymer-free coat...
“Hybrid” model likely to be a hallmark of the post-pandemic era for heart failure care
The pandemic saw a boom in the use of remote technologies and telehealth for patient monitoring ...
FDA approves coronary use of XO Cross support catheter system
Transit Scientific has announced US Food and Drug Administration (FDA) clearance of its XO Cross...
Quest International and CathWorks partner to scale up FFRangio
Quest International and CathWorks have announced a strategic partnership. Quest has been selecte...
VenusP-Valve gains CE mark
Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—VenusP-Valve—has received...
CeloNova to seek medical device partnerships
CeloNova BioSciences has announced the strategic decision to focus its core business on creating...
ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT
Patients treated with edoxaban for six months after a transcatheter aortic valve implantation (T...
Cardiovascular News’ top 10 most popular stories of March 2022
The most read stories from across Cardiovascular News in March 2022 include a wealth of late-breakin...
FEops Heartguide receives FDA clearance for LAAO planning capabilities
FEops has announced that it received authorisation from the US Food and Drug Administration (FDA...
First patient in Japan treated with Impella 5.5 with SmartAssist
Abiomed has announced that the first patient in Japan has been treated successfully with Impella...
First patient enrolled in BIOMICS study for CTO-PCI
Biosensors International has announced the enrolment of the first patient in the BIOMICS study, a pr...
ACC.22: Analysis finds lower rate of structural valve deterioration with TAVI than SAVR at five years
Patients who received a transcatheter supra-annular self-expanding heart valve had less structural d...
ACC.22: NACMI registry finds reducing rates of death among STEMI patients with COVID-19
Latest results from the North American COVID-19 STEMI (NACMI) registry reported a 25% reduction ...
ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis
A head-to-head comparison of fractional flow reserve (FFR) and intravascular ultrasound (IVUS) guide...
ACC.22: Three-year data show “durable blood pressure reductions” through renal denervation
Long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial have been presented during ...
ACC.22: “Promising” one-year results for Pascal device in CLASP-TR trial
Patients with tricuspid regurgitation (TR) who received a Pascal transcatheter valve (Edwards Lifesc...
Corvia announces publication of REDUCE LAP-HF II data
Corvia Medical has announced publication of analyses from its global, phase III REDUCE LAP-HF II...
ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) leads to a fast...
SafeCross transseptal balloon gets first commercial use
East End Medical has announced the first commercial use of its SafeCross transseptal radiofreque...
Philips launches Ultrasound Workspace at ACC.22
Royal Philips is launching an echocardiography image analysis and reporting solution—Ultrasound Work...
SCAI aims to minimise risks in medical proctoring of new techniques and technologies
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...
FDA approval granted for Mitris Resilia mitral valve replacement
Edwards Lifesciences has announced it received approval from the US Food and Drug Administration (FD...
Shockwave coronary IVL gains Japanese approval
Shockwave Medical’s C2 coronary intravascular lithotripsy (IVL) catheter has received regulatory app...
First patient enrolled in PICSO-AMI-V study
Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V study to evaluate Pi...
RADIANCE-II renal denervation trial completes enrolment
Investigators have completed enrolment in the RADIANCE-II pivotal trial of the Paradise ultrasound r...
Carmat sets date for resumption of implants of artificial heart system
Carmat, designer and developer of an advanced total artificial heart, has issued an update on it...
Deep learning tool could predict future myocardial infarction
Researchers have detailed the use of an artificial intelligence-enabled tool for atherosclerotic...
First-in-human study paves way for further clinical trials of Valvosoft
Cardiawave has announced the success of its first-in-human I (FIH I) safety and feasibility clinical...
Expert group sets out principles for device-led hypertension trials
A consensus document outlining design principles and outcome definitions for device-based therapies ...
Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system
Four radial cases using the PH Band System (Medical Ingenuities)—a novel medical device that is ...
Venus Medtech targets European growth with senior appointment
Venus Medtech has appointed Shakeel Osman as senior vice president of sales Europe, responsible for ...
Women less likely to receive cardiogenic shock treatment
Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to r...
Dyspnoea and fatigue “warning signs of greater risk” for NSTEMI patients
Only 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one ye...
Putting “stent regret” behind us
Nick West, chief medical officer and divisional vice president of Global Medical Affairs, Abbott...
Xeltis announces “promising outcomes” in restorative graft trials following EU financing
Xeltis has announced promising initial outcomes from two key vascular trials involving its restorati...
ACC issues clinical guidance on cardiovascular consequences of COVID-19
The American College of Cardiology (ACC) has issued an expert consensus decision pathway for the eva...
CSI’s Propel pVAD system gets first-in-human use
Cardiovascular Systems—CSI—has announced the first in-human experience with Propel, its first-genera...
First patient treated in study of PerQseal+ vessel closure device
Vivasure Medical has announced today that the first patient was treated in a US early feasibilit...
Cardiologists without borders
“When I was one year old, my father died in the war between Israel and Egypt and I was left with...
Ryan Egeland joins Big Sky Biomedical
Big Sky Biomedical has appointed Ryan Egeland as managing director.
“Big Sky Biomedical was f...
Medtronic expands reach of AI-powered surgical video management and analytics platform
Medtronic has announced that it has entered into a contract with Vizient to add Touch Surgery En...
Cardiovascular News’ top 10 most popular stories of February 2022
The most read stories from across Cardiovascular News in February 2022 include training for robotic ...
CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI
Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical outcomes after transcat...
CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition
A novel transcatheter system designed for transfemoral mitral valve repair—the NeoChord Nexus sy...
CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual antiplatelet therapy...
CRT 2022: Four-year LRT data “support TAVI in low-risk patients”
Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aortic valve implantatio...
VISION study concludes troponin is a benchmark for cardiac surgery risk
Levels of high-sensitivity troponin I after cardiac surgery that were associated with an increased r...
Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed
Biotronik has announced final enrolment in the BIOMAG-I clinical trial by Michael Haude (Rheinla...
CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX
Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientif...
Women underrepresented in cardiovascular clinical trial leadership positions
Women remain underrepresented in leading cardiovascular clinical trials, corresponding with unde...
CRT 2022 hears results of animal study of Tria TAVI valve
Results from the first animal study of the Tria transcatheter aortic valve (Foldax) have been pr...
CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years
Final five-year results from the BIOFLOW-V trial, presented during a late-breaking trial session...
Partnership to promote wearable tech in cardiology trials
Wearable technology and digital health specialist Activinsights has announced a partnership agreemen...
High coronary artery calcium score increases risk of heart attack or stroke
Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a mor...
CX 2022 returns to in-person format facing challenges and opportunities in the aortic field
Anticipation is building for the Charing Cross International Symposium 2022 (CX 2022). This will...
Teleflex catheters and coronary guidewires cleared for CTO PCI
Teleflex has announced that the US Food and Drug Administration (FDA) has cleared an expanded indica...
New data underpin drive towards earlier AF ablation strategies
Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have...
Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality
Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated with lower in-hospi...
Siemens introduces “integrated” cath lab imaging system, Artis icono biplane
Siemens Healthineers has announced the launch of Artis icono biplane—an angiography system with dete...
Ross procedure “associated with better long-term outcomes” for aortic valve replacement
The “Ross procedure” may be a more favourable option for aortic valve replacement among patients...
Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure
Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indicat...
On-pump and off-pump CABG confer similar outcomes over 10 years
A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary artery bypass graftin...
Heart team approach points to mortality benefit in complex cardiac patients
Consultation by a heart team led to an observed benefit in objective patient outcomes, a prospective...
New technique outperforms manual assessment of thoracic aortic aneurysm growth
Researchers have developed a novel method of measuring growth of thoracic aortic aneurysm, which the...
Robert Califf to return as US FDA commissioner
Cardiologist and researcher Robert Califf has been confirmed as the commissioner of the US Food ...
Expanded robotic training will benefit cardiovascular care
Robotic systems have the potential to fundamentally change the way care is delivered to patients in ...
3D printing to support physician training and coronary device testing
The donation of new 3D printing technology to the Visible Heart Laboratories at the University o...
Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant
Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled tri...
Boston Scientific closes acquisition of Baylis Medical Company
Boston Scientific has announced the close of its acquisition of Baylis Medical Company, a compan...
MedHub announces investment and pivotal study completion
MedHub has announced the completion of a funding round worth US$1 million in new financing, alongsid...
Supreme drug-eluting stent “safe and effective” in complex coronary lesions
The Supreme healing-targeted drug-eluting stent (Sinomed) is effective and safe at one year acro...
Portsmouth Hospital: How tech is guiding decision-making in the cath lab
Peter Haworth (Portsmouth Hospitals University NHS Trust, Portsmouth, UK) documents how computer-der...
HeartFlow and Longview terminate merger agreement
HeartFlow has announced that it and Longview Acquisition Corporation have mutually agreed to termina...
Lung cancer patients with higher level of coronary calcium at increased risk for adverse cardiovascular events
Lung cancer patients with higher amounts of coronary artery calcium have an increased risk of an adv...
IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation
The use of intravascular ultrasound (IVUS) guidance for implantation of drug-eluting stents in long ...
Cardiovascular News’ top 10 most popular stories of January 2022
The most read stories from across Cardiovascular News in January 2022 include controversy surroundin...
Acarix submits breakthrough designation request to FDA for heart failure diagnosis tool
Acarix has submitted a breakthrough designation request for its technology for heart failure diagnos...
“Game changing” photon-counting CT system arrives at John Radcliffe Hospital
The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundation Trust (OUH, Oxfor...
Philips expands haemodynamic assessment in its Lumify handheld ultrasound system
Royal Philips has announced an update to its handheld ultrasound platform—Lumify—adding Pulse Wave D...
Second phase of ASCENT ASD trial begins
Atheart Medical has announced that it has received US Food and Drug Administration (FDA) approva...
Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial
The placement of an interarterial shunt device—the Corvia atrial shunt (Corvia Medical)—did not ...
First patient enrolled in RISE SC study of coronary balloon
Biosensors has announced the enrolment of the first patient in the RISE SC study, a single arm, pros...
Breakthrough designation granted to CardiaAMP cell therapy system for heart failure treatment
BioCardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Devi...
CroíValve completes funding round for study of Duo system
CroíValve has raised a Series A round to fund a feasibility clinical study with its Duo Coaptati...
SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation
The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the release ...
Abbott’s Nick West points to future role of AI in the cath lab
Abbott has released a second round of insights from its Beyond Intervention global research prog...
ADVERTORIAL: Fresh data paint a positive picture for IVL in both eccentric and nodular coronary calcium
This advertorial is sponsored by Shockwave Medical.
The latest data from the Disrupt CAD clinical...
ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases
This advertorial is sponsored by Medtronic.
Evolut PRO+ is the latest generation of self-expandin...
Susheel Kodali
Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in New York, where he ...
Cardiovascular News 64 – February 2022: US Edition
In this issue:
Coronary revascularisation guidelines spark debate
New data on IVL in eccent...
Cardiovascular News 64 – February 2022: OUS Edition
In this issue:
Coronary revascularisation guidelines spark debate
New data on IVL in eccent...
STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery
Insights from what was described as the “largest and most comprehensive” analysis of isolated su...
PROACT clinical trial results published for On-X mechanical mitral valve
Artivion has announced the publication of PROACT clinical trial results in The Annals of Thoracic Su...
SCAI issues updated expert consensus statement on cardiogenic shock
The Society for Cardiovascular Angiography and Interventions (SCAI) has released its updated exp...
STS 2022: Closer ties between surgeons and cardiologists among goals for incoming president
Cardiothoracic surgeon John H Calhoon from The University of Texas Health Science Center (UT Hea...
STS 2022: Socioeconomic status may impact outcomes after mitral valve surgery
Patients with mitral valve disease who live in disadvantaged communities are more likely to expe...
InnovHeart completes funding round to advance Saturn TMVR system
InnovHeart, developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatme...
JIM 2022 moves to June slot
Organisers of the Joint Interventional Meeting (JIM) have announced that the 2022 edition of the eve...
First patient enrolled in TRANSFORM II study of sirolimus-coated balloon
The first patient has been enrolled in the TRANSFORM II randomised controlled trial assessing th...
“Considerable” reduction in PCI-related radiation reported in last decade
Radiation exposure during percutaneous coronary intervention (PCI) has fallen “considerably” during ...
Burden of aortic stenosis likely to challenge UK treatment capacity, researchers warn
Researchers have warned that the number of people suffering from aortic valve stenosis in the UK cou...
Grant funding for 3D-printed paediatric heart models
Congenita has been named a recipient of the MedTech NAVIGATOR Innovation Grant Scheme, run by NHS me...
Guidelines recognise potential role for earlier endovascular treatment of uncomplicated type B aortic dissection
New clinical practice guidelines have been published today, and are intended to act as “guard rails”...
Scoreflex NC PTCA catheter gains FDA premarket approval
Cardiovascular Systems (CSI) and OrbusNeich Medical Company have announced US Food and Drug Administ...
Gore’s Cardioform Septal Occluder reaches 10-year milestone
WL Gore & Associates has announced that its Cardioform Septal Occluder has achieved 10 years...
Young surgeons to benefit from Transatlantic grant scheme
In a joint programme between the Society of Thoracic Surgeons (STS) and the European Association...
TAVI associated with reduced odds of in-hospital mortality for bicuspid valve patients
A propensity score-matched analysis of the early outcomes of transcatheter aortic valve implantation...
Pioneering pig to human heart transplant heralded as a breakthrough
A 57-year-old patient with terminal heart disease received a successful transplant of a genetically-...
AATS and STS opt not to endorse joint coronary revascularisation guidelines
The American Association for Thoracic Surgery (AATS) and The Society of Thoracic Surgeons (STS) have...
Omicron surge sees STS move 2022 annual meeting online
The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an in-person to a virt...
Terumo welcomes upgraded recommendation for radial access in revascularisation guidelines
Terumo Medical Corporation has welcomed the publication of updated guidelines from the American Coll...
Robocath completes European study of robot-assisted PCI
Robocath has announced the conclusion of its R-Evolution clinical study in Europe, which was aimed a...
Impella gains a trio of regulatory approvals
Regulators in three countries have granted approvals to Impella surgical products. In the USA, the F...
Evolut PRO TAVI valve gains approval in China
Medtronic has announced that the National Medical Products Administration (NMPA) has approved th...
Cardiovascular News’ top 10 most popular stories of December 2021
The most read stories from December 2021 include analysis of the CHEETAH study and the role of mecha...
First patient enrolled in COSIRA-II trial of Neovasc Reducer
Neovasc has announced enrolment of the first patient in the COSIRA-II clinical trial.
COSIRA-II (...
Endotronix announces FDA approval for PROACTIVE-HF pivotal trial design change
Endotronix has announced that the US Food and Drug Administration (FDA) has granted approval for...
Partnership to develop training system for complex valve-in-valve procedures
Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partnering to develop a ne...
FDA clears CavaClear IVC filter removal laser sheath
Royal Philips has announced US Food and Drug Administration (FDA) de novo clearance for the Phil...
First clinical results for Tria biopolymer valve published
Foldax has announced publication of the first clinical results for its Tria biopolymer heart val...
Sapien 3 with Alterra prestent gains FDA approval
Edwards Lifesciences has received approval from the US Food and Drug Administration (FDA) for th...
Research suggests many patients may be safely discharged without opioids after cardiac surgery
Many patients undergoing cardiac surgery may be able to safely and effectively control postoperative...
EMPAKT CHF trial points to change in assessment acute heart failure patients
FAST BioMedical has announced the publication of additional results from the EMPAKT CHF (Estimating ...
Initial implants of Thubrikar TAVI system to commence
Thubrikar Aortic Valve has received approval from a Competent Authority in Poland to conduct initial...
AI improves confidence in CAD detection from a stress echocardiogram
Ultromics has announced the publication of a study assessing its EchoGo platform, powered by Art...
HeartFlow submits premarket application for coronary plaque assessment
HeartFlow has announced it has submitted a 510(k) premarket application to the US Food and Drug Admi...
“Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI
Results of the CHEETAH clinical study highlight the potential role of mechanical aspiration thro...
Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX
Svelte Medical Systems has received US Food and Drug Administration (FDA) approval to commercialise ...
Opsens files 510(k) submission to US FDA for TAVI guidewire
Opsens has filed a 510(k) submission with the US Food & Drug Administration (FDA) for regulatory...
Joanna Chikwe appointed as editor-in-chief of The Annals of Thoracic Surgery
The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the Department of Cardi...
Understanding the risk of acute kidney injury in the cath lab
Huge strides have been made in preventing contrast-associated acute kidney injury among patients...
Heart team approach central to updated coronary revascularisation guidelines
New guidelines for coronary artery revascularisation recommend that treatment decisions should be ba...
Coronary artery modelling technology enables 3D reconstruction of coronary vasculature
RSIP Vision has announced a new coronary artery modelling technology, which enables reconstruction o...
Philips expands cardiac ultrasound portfolio
Royal Philips has announced an expansion of its ultrasound portfolio with new imaging tools and ...
Foldax commences clinical study of Tria surgical aortic valve in India
Foldax has announced that the Drugs Controller General of India (DCGI), India’s regulatory body for ...
Venus Medtech announces Cardiovalve acquisition
Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitral and tricuspid val...
SyMap Medical closes US$100 million financing round
SyMap Medical has announced the completion of a financing round which will be used to accelerate...
Restore Medical announces preliminary results from first-in-human use of ContraBand
Restore Medical has announced preliminary results of the first-in-human clinical trial of ContraBand...
Survey: Bullying “commonly experienced” by UK cardiology trainees
One in 10 junior doctors training to be cardiologists in the UK say they have been bullied, the resu...
Interim REVERSE-IT trial results published in NEJM Evidence
Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceuticals), which is de...
Cardiovascular News’ top 10 most popular stories of November 2021
Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021, 4–6 N...
AI-based algorithm could predict outcomes after cardiac surgery
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunction from a single-l...
Soundbite Medical gains fifth US patent for its plaque modification technology
Soundbite Medical Solutions has announced that the US Patent and Trademark Office has issued a paten...
Robocath announces completion of first robotic coronary angioplasty with R-One in China
Robocath has announced the successful completion of what it has described as the first coronary angi...
TMVI is a “reproducible and reliable” tool for eliminating mitral regurgitation
Findings of the CHOICE MI registry show that transcatheter mitral valve implantation (TMVI) is a...
PCR London Valves 2021: ENVISAGE TAVI AF and the future of TAVI trials
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, presented...
Mirvat Alasnag
Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Currently the director...
CSI recalls Wirion embolic protection device
Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic protection systems ...
PCR London Valves: Two-year GALILEO data show comparable outcomes for TAVI with self-expanding or balloon-expandable valves according to physician discretion
Two-year findings of a post-hoc study from the GALILEO trial, investigating the clinical outcome...
PCR London Valves: First clinical data backs use of Jenavalve TAVI system in patients with aortic regurgitation
First clinical results of transcatheter aortic valve implantation (TAVI) using the Jenavalve sys...
PCR London Valves hears first results from NeoChord Nexus mitral repair device
The first 30-day results following the implantation of the NeoChord NeXuS transcatheter system f...
First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire
Opsens has announced the successful treatment of 20 patients leading to the completion of the first ...
First patients enrolled in FAST III study of vFFR-guided PCI
The first patients have been enrolled in the FAST III trial at the Erasmus University Medical Center...
ESC publishes pandemic guidance on diagnosis and management of cardiovascular disease
European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular dis...
SCAI pushes revised standardised language to improve cardiogenic shock care
New guidance on the diagnosis and presentation of cardiogenic shock aims to simplify and standar...
Findings of meta-analysis “move the conversation forward” on left main revascularisation
A meta-analysis comparing percutaneous coronary intervention (PCI) using a drug-eluting stent (D...
AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI
An updated risk score to predict possible contrast-associated acute kidney injury (CA-AKI) among...
AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG
Use of a novel, venous external support device (VEST, Vascular Graft Solutions) may lead to incr...
HeartVista receives FDA clearance for use of its AI software on Siemens MRI scanners
HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance to deliver its AI-ass...
AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation
Coronary artery bypass graft sugery (CABG) between two and three days after ticagrelor cessation was...
AHA 2021: Asymptomatic AS patients benefit from early valve replacement surgery
Asymptomatic patients with severe aortic stenosis (AS) may benefit from early aortic valve replaceme...
What to expect from AHA 2021
Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2021, 13–15 November,...
ADVERTORIAL Chronic total occlusion: The last frontier in the cath lab
This advertorial is sponsored by iVascular
Treatment of a chronic total occlusion (CTO)—a complet...
“Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021
Early data presented at the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021; ...
Abbott research highlights opportunities for improvements in diagnosis and treatment of cardiovascular disease
Abbott has released new research from its Beyond Intervention initiative, a multi-year global resear...
Ron Waksman joins SIS Medical AG advisory board
SIS Medical AG has appointed Ron Waksman, associate director Division of Cardiology, MedStar Was...
Lessons from SURTAVI
Transcatheter aortic valve implantation (TAVI) pioneer and principal investigator of the SURTAVI tri...
Cardiovascular Systems announces enrolment in first-in-human study of everolimus-coated coronary DCB
Cardiovascular Systems has announced the start of enrolment in a first in-human trial of the coronar...
Patients more likely to survive a cardiac arrest in the operating room than the cath lab
Patients who went into cardiac arrest in the cardiac cath lab were more likely to survive to hospita...
Two-year results of mitral valve repair using ChordArt device published
CoreMedic has announced the publication of two-year follow-up results from the first in-human CHAGAL...
Medtronic announces 2045 net zero emissions ambition to combat climate change
Medtronic has announced its ambition to achieve net zero carbon emissions by fiscal year 2045 across...
TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold
Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascular Therapeutics annu...
TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve
Six-month results from the TRISCEND study of the Evoque (Edwards Lifesciences) transcatheter tri...
TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system
Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral valve replacement (T...
TCT 2021: SWISS-APERO trial finds lower rate of peri-device leak in Amulet compared to Watchman FLX LAAC device
Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovascular Therapeutics an...
TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens
Patients receiving antiplatelet therapy following percutaneous coronary intervention (PCI) devel...
TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella
The final results of the PROTECT III and Restore EF prospective studies demonstrate improved out...
TCT 2021: LAAC remains non-inferior to NOAC for cardiovascular events at long-term follow-up
Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K-antagonists (NOACs)...
TCT 2021: Five-year SURTAVI data show comparable performance for TAVI and SAVR on mortality, stroke
Five-year clinical and echocardiographic outcome data from the SURTAVI randomised trial comparin...
TCT 2021: CHOICE-CLOSURE finds higher rate of access-related vascular complications in plug-based closure strategy post-TAVI
Results from the largest randomised trial to date comparing different closure device strategies ...
TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds
An economic analysis of data from the PARTNER 3 randomised trial, comparing transcatheter aortic...
TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart
Penumbra has announced that the CHEETAH clinical study of its Indigo system CAT RX catheter succ...
TCT 2021: “Sustained benefit” in patients undergoing IVL prior to coronary stenting
One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravascular lithotripsy (IV...
TCT 2021: Patients with diabetes undergoing PCI have less target lesion failure with amphilimus-eluting stents
Results from SUGAR, a randomised controlled, multicentre trial conducted exclusively in patients wit...
TCT 2021: Randomised trials show “consistent” reduction in blood pressure through renal denervation
Randomised placebo-controlled trials show consistently that renal denervation provides significant r...
TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing endovascular ultrasoun...
TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial
Lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed phys...
TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet no...
Cardiovascular News 63 – November 2021: US Edition
In this issue:
MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT)
...
Cardiovascular News 63 – November 2021: OUS Edition
In this issue:
MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT)
...
TCT 2021: Philips to showcase developments in its interventional portfolio
Royal Philips has previewed updates in its product portfolio and new data due to be shared at the Tr...
Procyrion’s Aortix percutaneous mechanical circulatory support device features at TCT 2021
Procyrion has announced the presentation of studies at the Transcatheter Cardiovascular Therapeutics...
Aktiia announces Series A funding round
Hypertension health-tech firm Aktiia has announced a US$17.5 million Series A round of funding t...
ReValve Solutions announces first use of its Palmetto mitral valve replacement system
ReValve Solutions has announced that it has successfully completed the first-in-human use of its tra...
TCT 2021: Studies to highlight patient outcomes with Impella
Results from two studies of the Impella heart pump device will be presented at the Transcatheter Car...
Bifurcation lesions: Exploring the latest science
This educational supplement, sponsored by Medtronic, explores the latest evidence covering the treat...
AHA and ACC release clinical guidelines for evaluation of chest pain
Joint clinical practice guidelines have been issued by the American Heart Association (AHA) and the ...
EACTS speakers question evidence underpinning guidelines for left main revascularisation
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 Octobe...
Longest available real-world follow-up data for Tendyne valve support use of device in select patients
The longest available real-world follow-up data of transcatheter mitral valve implantation (...
Enrolment completed in study of Teleflex QuikClot device
Teleflex announced the completion of patient enrolment in a clinical study evaluating the performanc...
Research finds poor level of surveillance following aortic dissection repair
Patients who survive an aortic dissection often fail to receive comprehensive post-surgical fo...
CRF waives cost for digital access to TCT 2021
The Cardiovascular Research Foundation (CRF) has announced that the digital component of the Transca...
PIONEER III trial results demonstrate safety and efficacy of HT Supreme stent
Sinomed has announced that the PIONEER III clinical trial results for its HT Supreme drug-elutin...
Cardiac CTA parameters predict post-TAVI mortality
Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) improves predictive pe...
First European implants of Trilogy TAVI system completed
JenaValve Technology has announced the first commercial implants with the Trilogy heart valve System...
Heartflow announces start of REVEALPLAQUE clinical trial
HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate the company’s non-inv...
Study charts “inequities” in growth of TAVI in US hospitals
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has predominantly centred...
Ethnic and racial minority cardiologists face professional discrimination and exclusion
Ethnic and racial minority cardiologists report career satisfaction but face professional discrimina...
EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials
The underrepresentation of women in clinical coronary revascularisation trials may encourage tre...
Clinical study of SavvyWire TAVI guidewire commences
OpSens has announced the commencement of the human clinical study utilising the SavvyWire, and succe...
Next generation of aortic surgeons need open and endovascular skills
Building and maintaining expertise in both open and endovascular surgical techniques will play a...
ReCor Medical’s Paradise ultrasound renal denervation system used in first German cases
ReCor Medical has announced that its Paradise ultrasound renal denervation system is now available f...
Baylis Medical Company to sell its cardiology business to Boston Scientific
Baylis Medical Company has reached an agreement to sell its cardiology business to Boston Scientific...
Philips’ Bert van Meurs discusses the future of imaging in the cath lab
Bert van Meurs is the chief business leader for Image Guided Therapy within Royal Philips, the multi...
NeoChord announces completion of first-in-human case with NeXus TMVr technology
NeoChord has announced successful completion of the first-in-human procedure with the NeoChord NeXuS...
Cardiovascular News’ top 10 most popular stories of September 2021
Top stories for September included more highlights from the European Society of Cardiology’s 2021 co...
Lankenau Heart Institute and Philips announced integrated cardiovascular solutions partnership
Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, USA) have announced ...
FDA monitoring gender differences in outcomes with LAAO devices
The US Food and Drug Administration (FDA) has informed healthcare providers of recent information ab...
Enrolment completed in study of Tria aortic valve
Foldax has announced completion of enrolment in the US early feasibility study of the Tria surgical ...
Siemens launches Luminos Impulse fluoroscopy system
Siemens Healthineers has launched the Luminos Impulse fluoroscopy system, including features such as...
Abbott’s Amplatzer Talisman gains FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's Ampla...
Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent
Biotronik has announced that it has received US Food and Drug Administration (FDA) approval of i...
Waiting list mortality for coronary procedures exacerbated during pandemic
Patients awaiting coronary artery bypass grafting (CABG) or percutaneous coronary intervention (...
Open Stent Solution closes €2.5 funding round
Open Stent Solution (OSS) has announced the closing of a €2.5 million Seed financing round. The fund...
HRX digital health event moved to September 2022
The Heart Rhythm Society (HRS) has announced that its cardiovascular digital health conference—HRX—h...
Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna
Capturing the latest developments in the comprehensive treatment of aortic disease—from the aortic v...
ADVERTORIAL: Optimising TAVI device choice
This advertorial is sponsored by Medtronic
As transcatheter aortic valve implantation (TAVI) ...
Neovasc to begin COSIRA-II trial of Reducer for refractory angina
Neovasc has announced that it has received Food and Drug Administration (FDA) approval for the inves...
FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company’s Epic ...
Registry data show comparable outcomes for bicuspid and tricuspid TAVI in low-risk patients
Patients at low surgical risk who had undergone transcatheter aortic valve implantation (TAVI) f...
Surgical team completes first implant of Aeson bioprosthetic heart in a female patient
A cardiothoracic surgical team with UofL Health–Jewish Hospital and the University of Louisville...
Ultrasound guidance “should be routine” for transfemoral TAVI access
Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI) is associated with...
Randomised trials needed to evaluate safety and efficacy of TMVR
Randomised trials are needed to evaluate the safety and effectiveness of transcatheter mitral va...
Abbott receives FDA approval for Portico with FlexNav TAVI system
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's P...
OpSens receives Health Canada approval to begin clinical study of TAVI guidewire
OpSens has announced that it has received Health Canada approval to commence the first in-man study ...
Renal denervation: The most advanced and efficacious interventional approach to treat hypertension
Following the release of the European Society of Hypertension’s (ESH’s) updated position paper o...
Long-term preclinical results of Xeltis’ restorative CABG graft presented at ISACB 2021
One-year data from preclinical trials of Xeltis restorative coronary artery bypass graft (XABG) show...
TCT 2021: Late-breaking trials programme announced
The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking trial and science pr...
ESH position paper highlights renal denervation as a third option for hypertension management
European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented ...
Peijia Medical announces first implant in the clinical trial of its TaurusNXT TAVI system
Peijia Medical has announced the initiation of its multicentre clinical trial for TaurusNXT, the...
Christoph Naber
Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career in interventional car...
New imaging technique has the potential to identify patients at high risk of aortic degeneration
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potential to identify patien...
CytoSorbents files IDE for clinical trial of DrugSorb-ATR used during cardiothoracic surgery
CytoSorbents has filed an investigational device exemption (IDE) application to gain US Food and Dru...
STENTiT makes trio of appointment to its medical advisory board
STENTiT, a medical device company bringing a novel class of regenerative endovascular implants f...
No-touch CABG technique “reduces risk of vein graft occlusion” after 12 months
When a modified surgical technique was used to gently remove sections of leg veins used in coronary ...
ABILITY Diabetes Global enrols thousandth patient
Concept Medical has announced the enrolment of the thousandth patient in ABILITY Diabetes Global (Ra...
Digital app speeds up time to STEMI care
“During a heart attack time is myocardium,” says Annapoorna Kini (New York, USA) discussing the ...
Cannabis use in younger adults linked to increased risk of myocardial infarction
Adults younger than 45 years who reported recently using cannabis were two times more likely to have...
Cardiovascular News’ top 10 most popular stories of August 2021
August’s top 10 features a stark warning over representation of women in clinical trials relating to...
HeartFlow announces enrolment of first three patients in FUSION trial
HeartFlow has announced that physicians at Erasmus MC Hospital (Rotterdam, The Netherlands) have...
ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS
Findings of the STOPDAPT-2 ACS trial presented during a hot line session at the European Society...
ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment
Abbott has announced late-breaking data from the Amulet LAA Occluder IDE trial, a multicentre, h...
ESC 2021: Drones touted as the future of defibrillator delivery
The world’s first feasibility study has found that drones can be used to deliver defibrillators to p...
ESC 2021: New guidelines for the diagnosis and treatment of acute heart failure published
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chr...
ESC 2021: Study charts impact of following health advice after a heart attack
Adherence to lifestyle advice and medications could add seven healthy years of life after a heart at...
Second hospital implants Aeson bioprosthetic artificial heart
CARMAT has announced the second centre implanting its bioprosthetic artificial heart, Aeson, in the ...
Medtronic gains FDA approval for its latest-generation TAVI system
Medtronic has announced US Food and Drug Administration (FDA) approval of its newest-generation, sel...
ESC 2021: Family history outweighed by lifestyle choices in study of premature heart attacks
Young heart attack victims are more likely to be smokers, obese, and have high blood pressure or...
EMPOWER trial to study Carillon mitral contour system
Cardiac Dimensions has announced the launch of the US pivotal study the EMPOWER trial, evaluatin...
Urgent TAVI patients more likely to be readmitted than elective cases
Readmissions within 30 days are more common following urgent, rather than elective, transcathete...
Cardiovascular News 62 – August 2021: OUS Edition
In this issue:
Meta analysis draws out debate on coronary revascularisation
What to expect w...
Cardiovascular News 62 – August 2021: US Edition
In this issue:
Meta analysis draws out debate on coronary revascularisation
What to expect w...
Ten-year outcomes of Yukon DES in diabetic patients published in JAHA
Translumina has announced the publication of 10-year clinical outcome data for its Yukon drug-elutin...
Ultromics completes US$33 million Series B funding round
Ultromics, a developer of AI enabled cardiovascular imaging solutions, has announced that it has rai...
FDA grants breakthrough device designation to Impella ECP
The US Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed...
Algorithm predicts heart failure hospitalisations
Biotronik has announced the results from a new study published in EP Europace this week confirming t...
Sinomed announces the first commercial implantation and European launch of the HT Supreme DES
Sinomed has announced the first commercial implantation of the HT Supreme drug-eluting stent (DE...
App launched to cut time to treatment for STEMI patients
Physicians at Mount Sinai Health System (New York, USA) have developed a mobile application to exped...
Second US FDA breakthrough device designation granted to CytoSorbents’ DrugSorb-ATR
CytoSorbents has been granted a second breakthrough device designation for its DrugSorb-ATR antithro...
Abbott’s Amplatzer Amulet gains US FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's ...
Occlutech gains IDE approval for OCCLUFLEX pivotal study
Occlutech Holding has announced the conditional US Food and Drug Administration (FDA) approval of it...
“Virtual contrast agent” could offer benefit in cardiac MRI assessment
An imaging technology developed using artificial intelligence (AI) could become an alternative for l...
Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform
Caption Health has announced that the Centers for Medicare and Medicaid Services (CMS) have appr...
Women underrepresented in cardiovascular clinical trials
Women remain underrepresented in cardiovascular clinical trials despite initiatives to ensure broade...
Realview Imaging gains FDA approval for Holoscope-i system
RealView Imaging has announced that it has received US Food and Drug Administration (FDA) 510(k) cle...
Back in the room: A welcome return to in-person education
With the COVID-19 pandemic having switched virtually all of the major meeting in the cardiovascu...
Cardiovascular News’ top 10 most popular stories of July 2021
Our top 10 stories of July 2021, including: A milestone for coronary balloon angioplasty; highlights...
Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19
The largest analysis of its kind to look at the impact of COVID-19 on adult cardiac surgery volu...
US launch for Abbott’s Ultreon AI-based coronary imaging platform
Abbott has announced that it has received US Food and Drug Administration (FDA) clearance for its la...
Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval
Edwards Lifesciences has announced that it has received regulatory approval from Health Canada for b...
PCI procedures drop by 10% in USA since 2010, research suggests
The USA saw a 10% decline in percutaneous coronary intervention (PCI) procedures between 2010 an...
AngelMed launches its Guardian device in the USA
Angel Medical Systems (AngelMed) has announced the first commercial implantation and US launch of it...
TVT 2021: MitraClip reduces hospitalisation in patients with secondary MR and heart failure
An analysis of the rates rehospitalisation and mortality in heart failure patients with secondar...
Medtronic launches Prevail DCB in Europe
Medtronic has announced the launch of the Prevail drug coated balloon (DCB) catheter in Europe follo...
ADVERTORIAL: DCB pioneer welcomes deliverability after first case with Medtronic’s brand new Prevail™ coronary DCB
This advertorial is sponsored by Medtronic
The first case using the Prevail (Medtronic) pacli...
CathWorks FFRangio system receives reimbursement approval in Japan
CathWorks has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has appr...
TVT 2021: Aborted TEER leads to poorer outcomes in mitral valve surgery
Among patients undergoing mitral valve surgery after failed transcatheter edge-to-edge mitral va...
TVT 2021: 3M study suggests minimalist TAVI is safe, leads to “substantial” cost savings
Clinical and economic results from the 3M TAVR economic study have been presented at TVT 2021 (T...
TVT 2021: Outcomes in low-risk bicuspid and tricuspid TAVI patients similar at one year
Patients with bicuspid aortic stenosis may benefit as much from transcatheter aortic valve impla...
TVT 2021: Two-year PINNACLE FLX results report low rate of ischaemic stroke for Watchman FLX
Two-year results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-...
MedAlliance launches Origin balloons for vessel preparation
MedAlliance has launched Origin SC and Origin NC, two high performance balloons for vessel preparati...
Ancora Heart secures US$80 million in financing
Ancora Heart has closed US$80 million in equity financing, with the funds to be used to accelera...
HeartFlow announces merger agreement
HeartFlow has entered into a definitive business combination agreement with Longview Acquisition...
First Aeson bioprosthetic artificial heart implanted in USA
Carmat has announced the first implantation of its bioprosthetic artificial heart, Aeson, in the USA...
Pacemaker implantation after SAVR points to increased mortality and heart failure hospitalisation
Patients undergoing permanent pacemaker implantation after surgical aortic valve replacement (SA...
First patients treated with reSept ASD occluder in IDE trial
atHeart Medical has announced the successful treatment of the first five patients in its ASCENT ...
FDA approval for SafeCross transseptal RF system
East End Medical has announced it has received US Food and Drug Administration (FDA) clearance f...
Cardiovascular societies demand action to combat physician burnout
Global action is needed to improve clinician wellbeing, according to four leading cardiovascular hea...
Xeltis initiates synthetic restorative pulmonary heart valve pivotal trial
Xeltis has announced that it has started a pivotal trial for a synthetic restorative pulmonary valve...
Common cath lab practices under the microscope in AHA review
The American Heart Association (AHA) has published a scientific statement challenging “tradition...
Cardiovascular News’ top 10 most popular stories of June 2021
Our top 10 stories of June 2021, including: Analysis of the data for transcatheter aortic valve impl...
CytoSorbents gains IDE for STAR-T trial to remove ticagrelor during cardiothoracic surgery
CytoSorbents has received approval for its investigational device exemption (IDE) application to con...
Carta Healthcare’s AI software certified for use in CathPCI Registry
Carta Healthcare has announced that it has been certified as a National Cardiovascular Data Registry...
Sinomed partners with NUI Galway for HT Supreme stent trial
Sinomed has announced a partnership with the National University of Ireland Galway (NUI Galway, ...
More experienced TAVI centres “less likely to use heart team approach”
Assessment of patients by both interventional cardiologists and cardiac surgeons prior to transc...
First patient treated with VeriSight Pro 3D intracardiac echocardiography catheter
Royal Philips has announced the first procedure using its real-time 3D intracardiac echocardiography...
Xience stent receives US FDA approval for short-duration DAPT
Abbott has today announced that its Xience family of stents has received US Food and Drug Admini...
Cardiothoracic surgery guidelines updated to optimise blood management among cardiac patients
Clinical practice guidance released today outline recommendations for reducing blood loss during...
Electroducer raises funding to market its external pacemaker device
Electroducer has announced that it has raised €3 million (US$3.65M) from private investors and Frenc...
Vaccine myocarditis risk “far outweighed” by COVID-19 infection
The risk of heart damage from COVID-19 infection is far greater than that from receiving a dose of t...
Pandemic contributes to worsening heart attack outcomes, study finds
Heart attacks during the COVID-19 pandemic were more likely to result in heart failure compared ...
AngelMed gains FDA approval for enhanced real-time cardiac monitor for ACS events
Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (FDA) approval of the...
One in eight CABG patients readmitted within 30 days, meta-analysis finds
Nearly one in eight coronary artery bypass graft (CABG) patients are readmitted within 30 days o...
Medtronic Canada completes end-to-end remotely-guided TAVI procedure
The first end-to-end remotely guided transcatheter aortic valve implantation (TAVI) procedure us...
Tendyne receives breakthrough designation for MAC patients
Abbott has received Breakthrough Device designation from the US Food and Drug Administration (FD...
Royal Philips announces start of DEFINE GPS study
Royal Philips has announced the official start of the DEFINE GPS study, with the first patient b...
Registry DAPT data “could support clinical trials”
Data captured in the National Cardiovascular Data Registry (NCDR) is similar in quality, depth a...
Long-term study finds QoL improvements in CABG patients despite complications
An investigation into the impact of postoperative complications on long-term quality of life (QoL) a...
Cindy Grines
Cindy Grines is an interventional cardiologist and chief scientific officer of Northside Hospital Ca...
PCI complexity does not influence efficacy of ticagrelor or prasugrel in acute coronary syndrome patients
In patients with acute coronary syndrome treated with percutaneous coronary intervention (PCI), ...
“Rapid increase” in cardiovascular disease-related deaths in Asia
The number of people dying from cardiovascular disease (CVD) in Asia is increasing rapidly, with ove...
Study of CorWave’s LVAD presented at ASAIO annual meeting
CorWave has announced that it has successfully completed the first 90-day preclinical study to evalu...
Circulation publishes special edition dedicated to disparities in cardiovascular medicine
Circulation the flagship journal of the American Heart Association (AHA) has published online its fi...
Shockwave’s coronary IVL device gains TPT payment approval
Shockwave Medical has announced today that the Centers for Medicare & Medicaid Services (CMS) ha...
Delaying CABG after AMI may not improve outcomes
A study looking at the timing of coronary artery bypass grafting (CABG) after the occurrence of acut...
Caution needed for TAVI in younger, low-risk aortic stenosis patients
Pivotal trials of transcatheter aortic valve implantation (TAVI) in low-risk patients have, so f...
Neurescue’s aortic occlusion device gains US FDA approval
Neurescue has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance ...
Pulmonary artery proportional pulse pressure monitoring could improve survival for heart failure patients
A new physiological measurement of heart function could improve survival for people with heart f...
TRISCEND study demonstrates significant reduction in TR with Evoque tricuspid valve
Early experience with the Evoque (Edwards Lifesciences) tricuspid valve replacement system demonstra...
GE Healthcare and ACC partner to advance AI in cardiology
GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and ...
Medtronic stops sale of its HVAD system
Medtronic is stopping the distribution and sale of the Medtronic HVAD system. This morning, the ...
Targeted healing: A new stent concept that could contribute to shortened DAPT
This advertorial is sponsored by Sinomed
As newer-generation drug-eluting stent (DES) technol...
Cardiovascular News’ top 10 most popular stories of May 2021
Our top 10 stories of May 2021, including highlights from both EuroPCR 2021 (18–20 May, virtual), an...
Physician gender does not impact outcomes in PCI patients
There does not appear to be a relationship between operator and patient gender and outcome in patien...
Siemens Healthineers receives CE mark for the ACUSON AcuNav Volume ICE catheter
Siemens Healthineers has announced that it has received CE Mark for the AcuNav Volume ICE (intracard...
LivaNova completes initial divestiture of its heart valve business
LivaNova has successfully completed the initial closing of the divestiture of its heart valve bu...
Female aortic dissection patients presenting later, have higher mortality
Women who experience acute aortic dissection are older, have more advanced disease than men when...
Abiomed acquires breakthrough device company preCARDIA
Abiomed has acquired preCARDIA, developer of a proprietary catheter and controller to expand options...
Sinomed announces presentation of PIONEER III data at EuroPCR 2021
Sinomed has announced results from the HT Supreme healing-targeted drug-eluting stent (DES), in ...
Patients at high risk of bleeding—A forgotten population in PCI?
There is an increasing understanding of the need for tailored strategies when treating high-bleedin...
COVID-19 puts a spotlight on the need for investment in resources for cardiac surgery
A call for greater investment in surgical facilities in the UK in the wake of the COVID-19 pandemic ...
EuroPCR 2021: Interventional cardiologists sound the alarm over silent impact of the pandemic
Interventional cardiologists from across the globe are joining forces for a campaign reinforcing...
Intravascular lithotripsy: Not an eccentric option for eccentric calcium
This advertorial is sponsored by Shockwave Medical.
Severe coronary artery calcification presents...
MDR comes into effect across EU
The European Union (EU) Medical Devices Regulation (MDR) takes effect from today (26 May 2021).
T...
First-in-human use of Tria biopolymer heart valve completed
Foldax has announced the successful first-in-human use of its biopolymer Tria heart valve in surgica...
First patients treated with Aortix pMCS device
Procyrion has announced the treatment of the first patients in the pilot trial to evaluate the perfo...
EuroPCR 2021: Image-guided PCI study demonstrates non-inferiority of ultra-thin stent
Investigation of the use of an ultra-thin strut biopolymer sirolimus-eluting (BP-SES; Orsiro, Bi...
RE-ACCESS study has implications for TAVI valve selection
This advertorial is sponsored by Boston Scientific
In recent years, transcatheter aortic valv...
TricValve transcatheter bicaval valve system receives CE mark
OrbusNeich and P&F Products & Features, under the joint partnership OrbusNeich P&F, have...
EuroPCR 2021: Study details dual mechanism of Diamondback orbital atherectomy system
Results of an observational study using optical coherence tomography (OCT) to assess the efficac...
EuroPCR 2021: FUTURE-II hints at promise for Firesorb bioresorbable scaffold
One-year results of the FUTURE-II study—a randomised trial comparing a thin-strut bioresorbable ...
EuroPCR 2021: Meta-analysis supports elective coronary revascularisation
A meta-analysis of randomised trials comparing a strategy of revascularisation plus medical therapy ...
ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI
Clopidogrel monotherapy produced better outcomes than aspirin for the long-term maintenance of p...
EuroPCR 2021: 10-year DISCOVER-FLOW results back HeartFlow FFRct analysis
HeartFlow has announced new data which indicate that the information provided by the HeartFlow F...
ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in PAD patients receiving rivaroxaban
Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, should be considered as a...
EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients
Complete two-year follow-up data from the Evolut Low Risk trial, presented during a late-breakin...
EuroPCR 2021: Biotronik touts two-year data from BIOSOLVE-IV registry
Long-term follow-up data from the BIOSOLVE-IV registry, presented at the EuroPCR 2021 meeting (1...
FAST II underscores vFFR as a “faster and easier” physiological lesion assessment tool
This advertorial is sponsored by PIE Medical
Findings of the multicentre FAST II clinical tri...
EuroPCR 2021: Registry data show low rates of PVL and PPI for Acurate neo2
Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress (18–20 M...
EuroPCR 2021: Philips shares cardiac imaging and software developments
Royal Philips has announced the European availability of new innovations in its portfolio of solutio...
ZOLL Medical receives FDA IDE approval for ISO Shock study
ZOLL Medical Corporation has announced that the US Food and Drug Administration (FDA) has approv...
Abbott’s Navitor TAVI system receives CE mark
Abbott has announced it has received CE mark for its latest-generation transcatheter aortic valve im...
ACC.21: High-sensitivity troponin T-test protocol did not improve outcomes in suspected ACS patients
Among patients with suspected acute coronary syndrome (ACS), the use of a high-sensitivity tropo...
ACC.21: Pandemic has seen burnout “double” among cardiology professionals
The proportion of cardiologists reporting burnout has nearly doubled during the COVID-19 pandemi...
ACC.21: FLOWER-MI finds no benefit to FFR-guided PCI in STEMI patients with multi-vessel disease
ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel disease undergoing percuta...
ACC.21: DAPT de-escalation may benefit AMI patients
Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) after 30 days was safe...
ACC.21: Registry data show low rate of stroke at one year following LAAO with Watchman
Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston Scientific) device ...
ACC.21: Apixaban not superior to standard of care following TAVI
Apixaban was not superior to standard of care following transcatheter aortic valve implantation ...
ACC.21: LAAO after heart surgery offers “new paradigm” for stroke prevention in AF patients
Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillation (AF), were much le...
COBRA PzF stent demonstrates long-term safety at five years post-PCI
CeloNova BioSciences that its COBRA PzF nanocoated coronary stent (NCS) achieved exceptional lon...
Philips adds haemodynamic measurement to Azurion image-guided platform
Royal Philips has announced the integration of its Interventional Hemodynamic system and portable pa...
Leaflex: Changing the conversation around aortic stenosis?
This advertorial is sponsored by Pi-Cardia
As more transcatheter aortic valve implantation (TAVI)...
Preventing kidney damage in the cath lab
This advertorial is sponsored by Osprey Medical
There is a growing recognition of the risk of con...
Hostile environment: Cardiologists report high prevalence of discrimination and harassment in the workplace
Discrimination and harassment are a common experience among those working in cardiology, according t...
Cardiovascular News 61 – May 2021: OUS Edition
In this issue:
Hostile environment: How cardiologists feel about discrimination in the workplac...
Cardiovascular News 61 – May 2021: US Edition
In this issue:
Hostile environment: How cardiologists feel about discrimination in the wo...
Study shows increasing diversity among US cardiothoracic surgery residents
Research presented at the American Association for Thoracic Surgery 101st Annual Meeting (AATS 2021,...
ACC.21: Digital app should replace stent cards as a patient PCI record
Fewer than half (48%) of patients undergoing percutaneous coronary intervention (PCI) still had ...
Cardiology trainees require preparation to adapt to shift towards telemedicine
A significant proportion of cardiology trainees are uncomfortable with using telemedicine and fe...
AGENT IDE trial to evaluate DCB-use in patients with coronary in-stent restenosis
Boston Scientific has announced it has initiated the AGENT IDE trial for the Agent drug-coated ballo...
Mild COVID-19 unlikely to lead to lasting heart damage
Mild COVID-19 infection is unlikely to cause lasting damage to the structure or function of the hear...
Abbott initiates trial focusing on twin AF and heart failure treatments
Abbott has announced a new trial focused on improving the treatment for people simultaneously battli...
Cardiovascular News’ top 10 most popular stories of April 2021
Our top 10 stories of April 2021, including: highlights from the Society for Cardiovascular Angiogra...
ACC.21: App speeds up time to PCI for STEMI patients
ST-elevation myocardial infarction (STEMI) patients received percutaneous coronary intervention (PCI...
SCAI names Timothy Henry as president
Timothy D Henry (The Christ Hospital Medical, Cincinnati, USA) has assumed the office of preside...
Mitral regurgitation patients treated with TEER will require mitral replacement surgery if treatment fails
Patients suffering from severe mitral regurgitation should be carefully screened and counselled befo...
Medtronic’s Evolut PRO+ TAVI system gains CE mark
Medtronic has announced that it has received the CE mark for the Evolut PRO+ transcatheter aorti...
SCAI 2021: ISCHEMIA trial population not reflected in real-world patients
Patients studied in the ISCHEMIA trial, the largest trial to date to compare revascularisation w...
SCAI 2021: Robotic PCI achieves high clinical and technical success “in a wide spectrum of lesions”
Robotic-assisted percutaneous coronary intervention (PCI) using the second-generation CorPath GR...
SCAI 2021: Prolonged DAPT “should remain the standard of care” in ACS patients
Analysis of the prospective Fuwai PCI Registry using selection criteria from the TWILIGHT trial, has...
SCAI updates consensus guidelines on cath lab standards
The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus...
SCAI 2021: Research lays bare the impact of the COVID-19 pandemic on STEMI care
Two research papers presented at the Society for Cardiovascular Angiography and Interventions vi...
SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique
Medtronic has announced results from an interim analysis of the first 171 patients (including 71...
Hospitalised COVID-19 patients at risk of developing heart failure
Patients hospitalised with COVID-19 may be at risk of developing heart failure even if they do n...
CE mark for BACE device for functional mitral regurgitation
Phoenix Cardiac Devices has announced that it has received CE mark for its Basal Annuloplasty of the...
CytoSorbents granted US FDA approval for STAR-T trial
CytoSorbents has announced that the US Food and Drug Administration (FDA) has granted conditional ap...
Societies publish initial findings of NACMI registry of STEMI patients with COVID-19
Initial findings from the North American Cardiovascular COVID-19 Myocardial Infarction (NACMI) R...
First patient enrolled in PROTECT IV randomised controlled trial of Impella
Abiomed has announced that the first patient has been enrolled in PROTECT IV, a large, prospecti...
Researchers create heart replicas from CT images
Researchers from King's College London (London, UK) have created 3D replicas of full-sized healthy a...
UK study suggests that COVID-19 patients are at elevated risk during cardiothoracic surgery
A retrospective observational study of patients undergoing cardiac surgery in the UK between March a...
Cardiothoracic surgeons mobilised for COVID-19 research
The work of the Cardiothoracic Surgical Trials Network (CTSN) in mobilising resources for COVID-19 r...
AcQCross transseptal crossing devices gain US FDA clearance
Acutus Medical has announced US Food and Drug Administration (FDA) clearance of the AcQCross family ...
First procedure performed in SMART head-to-head TAVI study
The first procedure has been completed in SMART (Small Annuli Randomized to Evolut or Sapien) po...
Next generation TriClip gains CE mark approval
Abbott has received CE mark for its next-generation TriClip transcatheter tricuspid valve repair sys...
Cardiovascular News’ top 10 most popular stories of March 2021
Our top 10 stories of March 2021, including: highlights from CRT 2021; converging TAVI and surgery o...
COVID-19 “lays the foundation for a digital shift in cardiovascular care”
More patients, particularly those with medical risk factors or from underserved communities, opt...
Understanding trends in TAVI and surgical aortic valve replacement
With recent data pointing to a shift towards more transcatheter aortic valve implantation (TAVI) pro...
Xience stent receives CE mark for short duration DAPT
Abbott has announced that its Xience stent has received CE mark in Europe for shorter duration o...
Dipti Itchhaporia begins term as ACC president
Dipti Itchhaporia has today begun her term as president of the American College of Cardiology (A...
Randomised trial data supports use of the PleuraFlow system
ClearFlow has announced clinical trial results published in the Journal of Cardiothoracic Surgery ev...
One in three female cardiologists report unwanted advances
More than a third of female cardiologists polled in a UK survey on discrimination and sexism in the ...
Older STEMI patients found to be more reluctant to undergo PCI in Chinese study
Patients aged over 65 years were more likely than their younger counterparts to turn down percutaneo...
How the LightLab initiative is examining the value of OCT in the cath lab
Matheen Khuddus (director of Cardiovascular Research, The Cardiac & Vascular Institute, Gainesvi...
B Braun and Infraredx collaborate on IDE clinical trial for the SeQuent Please ReX
B Braun Interventional Systems has announced a collaboration with Infraredx to accelerate the US Foo...
Alvimedica gains CE mark approval for Fluydo NC balloon catheter
Alvimedica has announced CE mark approval of Fluydo NC, its PTCA non-compliant balloon catheter.
...
Medtronic receives FDA approval for Harmony transcatheter pulmonary valve
Medtronic has received US Food and Drug Administration (FDA) approval for its Harmony transcatheter ...
Academic reputation does not determine following for interventional cardiology influencers
Social media has become an important platform for promoting research within the interventional cardi...
Cordella pulmonary artery pressure sensor reaches 100-implant milestone
Endotronix has announced the 100th global implant of the Cordella pulmonary artery pressure sens...
Viagra may prolong life for men with coronary artery disease
Men with stable coronary artery disease who receive Viagra due to impotence seem to live longer ...
Shockwave Medical to bring IVL to the Chinese market
Shockwave Medical has announced that the company has signed an agreement to form a joint venture wit...
Mavacamten granted US FDA new drug application
Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA) has accepted its n...
Stephan Achenbach
Stephan Achenbach is professor of medicine at the University of Erlangen, Erlangen, Germany and pres...
CRT 2021: Three-year COMPARE ABSORB results show similar TLF rate between Absorb scaffold and Xience stent
Three-year results from the COMPARE-ABSORB trial, presented during a late-breaking trial session...
CRT 2021: Polymer-free amphilimus-eluting stent non-inferior to zotarolimus-eluting stent in PCI patients
Three-year clinical outcomes from the Recre8 trial, a multicentre study comparing the safety and eff...
Lab-grown heart valves capable of growth in recipient, research finds
Lab-created heart valves implanted in young lambs were capable of growth within the recipient, a...
Imbio receives FDA 510(k) clearance for cardiothoracic imaging algorithm
Imbio has received US Food and Drug Administration (FDA) 510(k) clearance for its RV/LV Analysis alg...
Cardiovascular Systems announces first uses of Wirion embolic protection system
Cardiovascular Systems has announced that the first patients in the USA have been treated with the W...
CytoSorbents files IDE for US trial on ticagrelor removal during cardiothoracic surgery
CytoSorbents has announced the filing of an investigational device exemption (IDE) application to co...
Elixir Medical commences INFINITY-SWEDEHEART randomised study of DynamX bioadaptor
Elixir Medical has today announced commencement of the INFINITY-SWEDEHEART randomised controlled tri...
CardioRisk: Addressing atherosclerotic risk factors among Egypt’s ACS patients
Ahmed Bendary (Benha University, Benha, Egypt) details the CardioRisk project, an initiative to ...
CRT 2021: BIOSTEMI shows superiority of Orsiro stent to Xience for target lesion failure at two years
Two-year follow-up data the BIOSTEMI trial, presented during a late-breaking trial session at th...
CRT 2021: One-year outcomes after TAVI in low-risk bicuspid aortic stenosis patients meet expectations
Clinical outcomes up to one year after transcatheter aortic valve implantation (TAVI) in low-ris...
Five-year results of Gore REDUCE clinical study published
Five-year follow-up results from the Gore REDUCE study, assessing the Gore Cardioform or Helex s...
ACC.21 late-breaking clinical trial programme announced
The American College of Cardiology (ACC) has announced a number of the late-breaking clinical trials...
CRT 2021: Registry data highlights growing use of DOACs among bioprosthetic heart valve patients
Registry data charting the use of direct oral anticoagulants (DOACs) in patients receiving mecha...
CRT 2021: Registry data finds BASILICA has a low coronary artery obstruction rate
Data from an international registry of patients undergoing a procedure known as BASILICA, which ...
Cardiovascular News’ top 10 most popular stories of February 2021
Our top 10 stories of February 2021, including: the relationship between TAVI volumes and outcomes; ...
Approval allows use of single access Impella procedure across Europe
Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single acces...
ControlRad Select imaging system gains FDA market clearance
ControlRad has announced US Food and Drug Administration (FDA) 510(k) clearance to market Contro...
Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial
Favourable rates of ischaemic outcomes were observed among selected high bleeding risk patients ...
Societies collaborate to develop universal heart failure definition
A global collaboration between international heart failure bodies seeks to standardise the language ...
MedAlliance gains FDA breakthrough designation for sirolimus DEB treatment of de novo coronary lesions
MedAlliance has been awarded breakthrough status for Selution SLR, its sustained limus release drug-...
ICS announces first use of its Emblok system in Europe
Innovative Cardiovascular Solutions (ICS) has announced the success of its first European clinic...
FDA approval for Viola clampless proximal anastomosis device
Vascular Grafts Solutions has announced receipt of marketing clearance from the US Food and Drug Adm...
Two-year PARTNER 3 outcomes show convergence between TAVI and surgery on stroke and death
Two-year outcomes of the PARTNER 3 clinical trial, in which low surgical risk aortic stenosis pa...
CRT 2021: Analysis compares cangrelor favourably to glycoprotein IIB
An analysis of antiplatelet therapies used during percutaneous coronary intervention (PCI) has c...
Analysis shows proportionality fails to account for divergent COAPT and Mitra-FR trials
A secondary analysis of the COAPT trial, which sought to account for differences in the findings...
Data support use of AI to accurately estimate lesion-specific ischemia
Elucid, a developer of AI software to enable cardiovascular disease detection, has announced the pub...
Inovise gains breakthrough designation for non-invasive heart failure management system
Inovise Medical has announced that the US Food and Drug Administration (FDA) has granted breakth...
Occlutech announces completion of enrolment in study of atrial flow regulator in heart failure patients
Occlutech has announced the completion of patient enrolment in its pilot study to assess safety and ...
CRT 2021: DISRUPT CAD III sub-study shows efficacy of IVL in patients with longer lesions
A sub-analysis of the DISRUPT CAD III clinical trial, investigating use of Shockwave intravascul...
IVL is a safe and predictable tool against coronary calcium
After Shockwave Medical announced that its intravascular lithotripsy (IVL) technology received pre-m...
Terumo reaches agreement to acquire predictive analytics specialist Health Outcomes Sciences
Terumo Corporation has signed a definitive agreement to acquire all assets of Health Outcomes Scienc...
ACC.21 switches to a virtual-only meeting
The American College of Cardiology (ACC) has announced that its 70th annual scientific session, will...
Urgent action needed to address growing burden of heart failure
Urgent action is needed to address the growing burden of heart failure and the impact of COVID-1...
CRT 2021: Recre8 sub-analysis points to higher rate of clinically relevant bleeding in HBR patients during DAPT
A sub-analysis of the Recre8 trial, assessing patients at high bleeding risk (HBR) undergoing pe...
Study shows AI can “extend the reach” of echocardiographic assessment
Caption Health has announced the publication of a study in JAMA Cardiology assessing its artific...
OpSens gains CE mark for OptoWire III
OpSens has received CE mark approval for the OptoWire III, the latest generation of its flagship pro...
MRI study of COVID-19 patients with raised troponin levels reveals high rate of heart damage
Around 50% of patients who have been hospitalised with severe COVID-19 and have raised levels of...
What role will remote robotic procedures play in the future of PCI?
With the COVID-19 pandemic creating new barriers to the accessibility of healthcare, the success...
Teleflex completes enrolment in CTO-PCI IDE study
Teleflex has announced the completion of patient enrolment in a clinical study evaluating the perfor...
Shockwave IVL receives US FDA pre-market approval for severely calcified coronary artery disease
Shockwave Medical has announced that its intravascular lithotripsy (IVL) technology has received pre...
Ticagrelor monotherapy associated with a lower bleeding risk than standard DAPT after PCI
Dropping aspirin shortly after percutaneous coronary intervention (PCI) is associated with lower...
Substantial reduction in tricuspid regurgitation reported in 30-day outcomes of CLASP TR study of Pascal device
A study detailing early experience of the Pascal transcatheter valve system (Edwards Lifescience...
Off-pump CABG “an effective option” for patients with reduced ejection fraction
Off-pump coronary artery bypass grafting (OPCABG) is a safe and effective option for the treatment o...
Global heart failure cases soar since 1990
The number of patients with heart failure worldwide nearly doubled from 33.5 million in 1990 to 64.3...
Robotic treatment starts with the heart
Robotic-assisted treatment is on the cusp of achieving its full potential, says J Aaron Grantham, co...
New recommendations issued on antithrombotic treatment of AF patients undergoing PCI
Updated recommendations on the optimal antithrombotic treatment of patients with atrial fibrillation...
Meta-analysis points to “inverse” relationship between TAVI centre volume and outcomes
The authors of a systematic review and meta-analysis, looking at the effect of institutional tra...
First patient enrolled in SUCCESS PTA post-market study of Selution drug-eluting balloon
MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study...
iVascular announces availability of Angiolite DES for longer lesions
iVascular has announced that its Angiolite drug-eluting stent (DES) is available 44mm and 49mm lengt...
Philips completes acquisition of cardiac diagnostics specialist BioTelemetry
Royal Philips has announced that it has completed the acquisition of BioTelemetry, a US provider of ...
Puzzle Medical receives breakthrough designation for its transcatheter pump device
Puzzle Medical has announced that the US Food and Drug Administration (FDA) has granted the company ...
First European patient treated with Diamondback 360 coronary orbital atherectomy system
Cardiovascular Systems has announced that the first patient in Europe has been treated with its ...
COVID-19 patients at greater risk of death after cardiac arrest
COVID-19 patients who suffer a cardiac arrest either in or out of hospital are far more likely to di...
Rate of target vessel failure “significantly lower” after IVUS-guided PCI
Drug-eluting stent implantation guided by intravascular ultrasound (IVUS) is associated with signifi...
Study documents “surprisingly benign” impact of COVID-19 among cardiac surgery patients
A study published in the Journal of Cardiac Surgery, detailing 18 out of a group of 19 patients who ...
Minimally invasive aortic valve surgery or TAVI: The need for randomised trials
Minimally invasive aortic valve replacement (miAVR) in select patients with severe aortic stenos...
Comparative study reports favourable outcomes for VasoStat haemostasis device
Forge Medical has announced the publication of results of an investigator-initiated randomised trial...
STS 2021: Risk of burnout “a growing concern” in cardiothoracic surgery
The risk of burnout among cardiothoracic surgeons has been heightened by the COVID-19 pandemic, ...
STS 2021: Sean C Grondin elected STS president
Cardiothoracic surgeon Sean C Grondin from the University of Calgary (Calgary, Canada) has been elec...
STS 2021: Five-year COMMENCE results favour Resilia tissue aortic valve
Five-year data from the COMMENCE clinical trial, presented at the 57th annual meeting of the Soc...
STS 2021: Study identifies significant gender disparities in CABG
Women are significantly less likely than men to undergo coronary artery bypass grafting (CABG) using...
STS 2021: Cardiothoracic surgery suffers due to COVID-19
The COVID-19 pandemic has caused a substantial decline in overall heart surgery volume in the US...
STS 2021: Study of Impella 5.5 reports 79% survival rate at explant
A study of 356 patients treated with Impella 5.5 with SmartAssist (Abiomed) at 16 US and German cent...
Analysis of ADAPT-DES registry grades risk of stent thrombosis after PCI
An analysis of data from the ADAPT-DES registry, published in JACC: Cardiovascular Interventions, in...
Ancora Heart enrols first patient in the CORCINCH-HF study
Ancora Heart has announced enrolment of the first patient in the CORCINCH-HF pivotal trial, whic...
EU patients enrolled in REVERSE-IT trial of bentracimab for reversal of antiplatelet effects of ticagrelor
PhaseBio Pharmaceuticals has expanded its pivotal phase 3 REVERSE-IT trial for bentracimab into the ...
Cardiovascular News 60 – February 2021: OUS Edition
In this issue:
Long-term registry data show TAVI has overtaken surgical aortic valve replacemen...
Cardiovascular News 60 – February 2021: US Edition
In this issue:
Long-term registry data show TAVI has overtaken surgical aortic valve replacemen...
SIS Medical announces publication of results of ISAR-CALC study for its high-pressure balloon catheter
SIS Medical has announced the publication of the ISAR-CALC—ComparIson of Strategies to PrepAre SeveR...
Scoring systems may overstate risk of minimally invasive aortic valve procedures
Current scoring systems used to assess the risk of mortality in minimally invasive aortic valve ...
NHS England mandates adoption of HeartFlow analysis for coronary heart disease
HeartFlow has announced that National Health Service England (NHSE) and NHS Improvement have man...
Study backs biopolymer used in Foldax’s Tria valve
Foldax has today announced publication of a research paper in Advanced NanoBiomed Research that ...
Alleviant Medical receives FDA breakthrough designation for transcatheter technology
Alleviant Medical has announced that the US Food and Drug Administration (FDA) has granted the compa...
Aktiia’s wrist-mounted blood pressure monitor gains CE mark
Aktiia has announced that its automated blood pressure monitoring system has received the CE mar...
Social determinants key in assessing coronary heart disease risk
A patient’s risk of coronary heart disease may be more accurately predicted by taking into accou...
Patients “fearful” of seeking cardiac care during pandemic
Analysis of data from English hospitals suggests that there was a sharp decline in the number of peo...
“A huge loss to the cardiology community”: Tributes paid to Prof David Foley
Tributes have been paid to David Foley, professor of Interventional Cardiology at Beaumont Hospital,...
Diamondback 360 atherectomy system gains CE mark
Cardiovascular Systems has received the CE mark for its Diamondback 360 coronary orbital atherec...
Elixir Medical announces treatment of first patient in BIOADAPTOR trial
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced that...
Abbott receives expanded Medicare reimbursement for MitraClip
Abbott has announced that the US Centers for Medicare & Medicaid Services (CMS) has revised ...
Occlutech’s atrial flow regulator receives breakthrough designation for heart failure patients
Occlutech has announced that the US Food and Drug Administration (FDA) has granted a breakthrough de...
“This is the tip of the iceberg” warns BHF as cardiothoracic surgeries cancelled
The British Heart Foundation (BHF) has warned of the potentially dire consequences caused by the mas...
iVascular announces 6mm maximum overexpansion capacity for Angiolite DES
iVascular has announced that its Angiolite drug-eluting stent (DES) offers a 6mm overexpansion capac...
Complete revascularisation achieved in one quarter of patients with acute MI complicated by cardiogenic shock
Complete revascularisation is rarely achieved in patients with multivessel coronary artery disea...
First remote robotic-assisted PCI completed in Europe using R-One platform
Robocath has announced the successful completion of the first remote robotic-assisted percutaneo...
The Foundry announces first-in-human procedure in study of Half Moon TMVR device
The Foundry today announced the completion of the first-in-human procedure with the Half Moon Medica...
Inari Medical’s FlowTriever receives FDA clearance for treatment of right atrial clot in transit
Inari Medical has announced US Food and Drug Administration (FDA) 510(k) clearance of the FlowTrieve...
Medtronic gets Health Canada approval for use of Evolut in low-risk aortic stenosis patients
Medtronic Canada has received a new expanded indication from Health Canada for its Evolut transc...
ACC.21 to offer remote COVID-19 screening
The American College of Cardiology (ACC) is partnering with BioIntelliSense, a continuous health mon...
CathWorks raises funds to support commercialisation of FFRangio system
CathWorks reported the completion of a US$30 million Series D financing round, proceeds from whi...
“Change in culture” needed to increase RCTs in cardiothoracic surgery
Specialists in congenital and adult cardiac and thoracic surgery have called for a cultural chan...
David J Cohen joins CRF as director of clinical and outcomes research
The Cardiovascular Research Foundation (CRF) has announced today David J Cohen has joined the or...
Acute heart failure patients see mortality risk double with COVID-19
Patients with acute heart failure nearly double their risk of dying if they get COVID-19, accord...
Ultromics receives FDA clearance for EchoGo Pro
The US Food and Drug Administration (FDA) has cleared the use of EchoGo Pro an aritificial intel...
CorWave secures €35 million investment
CorWave has rasied €35 million to fund the next stages of its development. The capital increase is s...
Heart failure specialist joins ALIVE Trial of Revivent transcatheter system
BioVentrix has announced that heart failure specialist Jerry Estep (Cleveland Clinic, Cleveland,...
VDYNE secures funding for studies of tricuspid valve replacement device
VDYNE has announced today that it has secured a US$21 million Series C financing, proceeds of which ...
ADVERTORIAL: What does SCOPE II tell us about TAVI device trials?
This advertorial is sponsored by Boston Scientific
Results of the SCOPE II clinical trial wer...
Jian’an Wang named as editor of JACC: Asia
Jian’an Wang (Heart Center, Zhejiang University, Hangzhou, China) has been named the inaugural edito...
First US patient treated in trial of Harpoon mitral valve repair system
Edwards Lifesciences has announced that the first patient has been treated in the RESTORE clinic...
Sharing international insight to improve the cardiovascular treatment pathway
Michael Poon (Lenox Hill Hospital-Northwell Health, New York, USA) discusses the progress made in tr...
Sapien 3 valve approved for treatment of severe symptomatic aortic stenosis in Canada
Edwards Lifesciences has announced that Health Canada has approved the expanded use of the Edwar...
Abbott’s HeartMate 3 LVAD receives approval for paediatric use
Abbott has announced that the US Food and Drug Administration (FDA) has approved updated labelli...
Analysis of STEMI patients finds little difference between prasugrel and ticagrelor after PCI
A subgroup analysis of the ISAR REACT-5—Intracoronary Stenting and Antithrombotic Regimen: Rapid Ear...
New valvular heart disease guidelines recognise expanding role of TAVI
New joint clinical practice guidelines on the treatment of patients with valvular heart disease have...
MagicTouch SCB granted breakthrough designation for the treatment of small coronary artery lesions
Concept Medical has been granted "Breakthrough Device Designation" from the Center for Devices and R...
Optimising pharmacology after transcatheter aortic valve replacement: Lessons from the POPular TAVI trial
Writing for Cardiovascular News, Harold Dauerman, Rony Lahoud and Newton Phuong from the Univers...
Investigational device exemption granted for Tria biopolymer mitral valve
Foldax has announced that the US Food and Drug Administration (FDA) has granted investigational devi...
Paying patients less likely to develop complications after cardiac surgery
Paying patients are 20% less likely than NHS patients to die or develop major complications, suc...
Abiomed completes first stage in early feasibility study of ECP heart pump
Abiomed has announced that its Impella ECP heart pump has completed the first stage in its US Food a...
CardioFlux imaging system granted Breakthough Device Designation
Genetesis has announced that its flagship product, CardioFlux, has been granted Breakthrough Device ...
ACC partners with Amgen and Veradigm on TRANSFORM: ACS study
The American College of Cardiology (ACC) will collaborate with Amgen and Veradigm on a study to ...
Corindus announces global launch of technIQ procedural automation series for CorPath GRX system
Corindus has announced today global launch of a new set of automated robotic movements in the te...
European launch for Acutus Medical’s AcQCross transseptal crossing system
Acutus Medical has announced CE mark approval and the European launch of its integrated family of tr...
Leaders in cardiothoracic surgery to consider impact of COVID-19 on the field
Global leaders in the field of cardiothoracic surgery will debate the impact of the COVID-19 pandemi...
Abbott launches virtual reality training programme for cardiologists using OCT imaging technology
Abbott has announced the global release of its first virtual reality-based training programme design...
Enrolment in Dan-NICAD II study of non-invasive diagnostic testing system completed
Acarix has announces the enrolment of the final patient in the Dan-NICAD II study of non-invasiv...
Staged strategy may be associated with improved outcomes when treating mitral regurgitation post-TAVI
The first international registry of patients undergoing transcatheter mitral interventions after tra...
Pre-existing coronary arterial disease linked to higher rate of myocardial infarction in patients receiving MitraClip
Pre-existing coronary arterial disease (CAD) was associated with higher in‐hospital acute myocardial...
LivaNova reaches agreement to sell its heart valve business
LivaNova has entered into an agreement with investment firm Gyrus Captial whereby entities funde...
Cathy Gates named as ACC’s new CEO
Cathy Gates has been named as the new CEO of the American College of Cardiology (ACC), effective...
Cardiothoracic surgery “stifled” during COVID-19 pandemic
Reduced effectiveness of treatment and increased running costs are likely to have driven down the co...
VersaCross RF Transseptal device found to be efficient for TMVR procedures
Baylis Medical has announced the publication of data demonstrating procedural efficiency for Mit...
Scoring system stratifies “dual” risk in aortic stenosis patients
A study published in the Journal of the American College of Cardiology (JACC) has detailed a scoring...
Women face a higher risk of heart failure after STEMI
Women face a 20% increased risk of developing heart failure or dying within five years after their f...
Vectorius granted breakthrough designation for V-LAP left atrial pressure sensor
Vectorious Medical Technologies has announced that the US Food and Drug Administration (FDA) has gra...
Philips launches IntelliSpace Portal 12 with updated cardiology imaging
Philips has announced the next generation of its advanced visualisation workspace—IntelliSpace Porta...
Gore announces encouraging early results for its pulmonary valved conduit
Gore has announced encouraging clinical results from its early feasibility study evaluating the safe...
PCR Valves: CUTTING-EDGE registry provides first look at long-term data on surgical procedures after transcatheter valve failure
Long-term data on the outcomes of surgery after failed transcatheter edge-to-edge mitral valve r...
PCR Valves: MitraClip G4 shows positive results in EXPAND G4 study
Data from the EXPAND G4 study, evaluating the performance of the latest generation MitraClip (Ab...
PCR Valves: Eight-year findings of NOTION I trial show comparable rates of mortality and stroke for TAVI and surgical valve replacement
Eight-year findings from the NOTION I trial—the first all-comers trial to randomise low-risk pat...
“Positive outlook” for transcatheter edge-to-edge treatment of mitral regurgitation
Emerging data supports transcatheter techniques to treat primary mitral regurgitation, according...
PCR Valves: “Encouraging” early results from DragonFly transseptal mitral valve presented
Details of an early feasibility study of transcatheter mitral edge-to-edge repair using the Drag...
PCR Valves: Valve-in-valve replacement should be standard of care for high-risk patients
Two-year outcomes from the MITRAL trial, presented at PCR Valves e-course (22-24 November, virtu...
PCR Valves: EXPAND registry reports favourable outcomes compared to COAPT
One-year findings from the EXPAND registry, evaluating real-world use of newer-generation MitraC...
PCR Valves: ACTIVATION trial finds no difference in one-year mortality or rehospitalisation from PCI prior to TAVI
The first randomised trial comparing a course of pre-procedure percutaneous coronary interventio...
Already the gold standard? PCR Valves panellists probe accumulating TAVI evidence
Discussion during the first day of the PCR Valves e-course (22–24 November, virtual) centred on ...
Tributes paid following death of esteemed UK cardiologist Anthony Gershlick
University of Leicester and University Hospitals of Leicester NHS Trust (UHL), Leicester, UK have an...
3D-printed heart model could be used in preparation for surgical training
A study published in ACS Biomaterials Science & Engineering details the development of a 3D-prin...
Corvia completes randomisation in REDUCE LAP-HF II trial
Corvia has announced completion of randomisation in its REDUCE LAP-HF II global, pivotal trial. ...
Boston Scientific discontinues Lotus Edge TAVI device
Boston Scientific has announced a global recall of all unused inventory of its Lotus Edge transc...
AHA 2020: Sinomed announces positive safety and efficacy data from PIONEER III study
Sinomed has announced the presentation of data from its inter-continental PIONEER III study comp...
TAVI overtakes surgical aortic valve replacement in the USA
The volume of transcatheter aortic valve implantation (TAVI) procedures in the USA exceeded surg...
AHA 2020: AF detected more often in high risk patients recovering from cardiac surgery
Atrial fibrillation (AF) was detected up to 10 times more frequently in high risk patients recov...
AHA 2020: Patients taking statins experience similar side effects from placebos
Among patients who stopped taking statins due to side effects, researchers found the statin may ...
AHA 2020: One-month DAPT safe and feasible after stent placement
A one-month treatment of dual anti-platelet therapy (DAPT) is safe and as effective as a longer ...
AHA 2020: Ticagrelor not superior to clopidogrel in reducing severe complications after PCI
The use of ticagrelor was not superior to clopidogrel in the reduction of the rate of severe com...
AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves
The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart disease and Atrial Fibri...
Transcatheter repair strategy for tricuspid regurgitation associated with improved outcomes
A pooled analysis of interventional studies assessing the feasibility, efficacy and clinical out...
Append Medical completes transcatheter implant-free LAA occlusion procedures
Append Medical, developer of the Appligator implant-free left atrial appendage (LAA) occlusion d...
Michael Reardon
A pioneer in the field of transcatheter aortic valve implantation (TAVI), Michael Reardon (professor...
Higher risk in heart valve procedures performed by early-career cardiothoracic surgeons
Heart valve procedures performed by cardiothoracic surgeons with 10 years of experience or less are ...
American Heart Association issues call for action on structural racism in cardiovascular care
Structural racism is a major cause of poor health and premature death from heart disease and stroke,...
Results from Onyx One Clear study published
Results of the Onyx One Clear study, evaluating the safety and effectiveness of one-month dual a...
First 1,000 patients treated with Impella 5.5 with SmartAssist
Abiomed has announced that the first 1,000 patients have been treated with the Impella 5.5 with Smar...
England’s first COVID-19 lockdown led to a significant drop in PCI procedures
A significant decline in percutaneous coronary intervention (PCI) procedures was seen in England...
Study draws link between physician payments and device selection
Payments from device manufacturers to physicians are likely to have a bearing on device selection in...
AstraZeneca receives EU approval for heart failure drug Forxiga
AstraZeneca’s Forxiga (dapagliflozin)—known as Farxiga—has been approved in the European Union (EU) ...
Ticagrelor may not be superior to clopidogrel in ACS patients undergoing PCI
The use of ticagrelor in patients with acute coronary syndrome (ACS) undergoing percutaneous coronar...
Recipients of MyoSeed research funding announced
MyoKardia has announced three awardees of the 2020 MyoSeeds research grant programme, who have been ...
The benefits of optical coherence tomography in the cath lab
Kevin Croce, director, Chronic Total Occlusion and Complex Percutaneous Coronary Intervention Pr...
Heart failure patients with COVID-19 at increased risk of death, JACC study finds
COVID-19 patients with a history of heart failure were associated with a longer duration of hospital...
Late-breaking science is alive and well despite the pandemic
Late-breaking science in interventional cardiology is alive and well despite the COVID-19 pandemic. ...
First patients treated with the Impella ECP heart pump
Abiomed has announced the treatment of the first two patients using the Impella ECP expandable percu...
Panel explores the unanswered questions around short duration DAPT
Mounting evidence over the safety and efficacy of shorter-term dual antiplatelet therapy (DAPT) ...
Foldax receives US FDA approval to expand clinical study of novel biopolymer aortic heart valve
Foldax has announced that the US Food and Drug Administration (FDA) has granted approval to expand t...
ESC events to continue digitally in 2021, society announces
The European Society of Cardiology (ESC) has announced that its full portfolio of congresses, teachi...
BioCardia shares early data from phase III CardiAMP cell therapy trial
BioCardia has announced the publication of data from the initial open-label roll-in cohort that serv...
Study assesses cardiac troponin elevation and presence of echocardiographic abnormalities in COVID-19 patients
A study published in the Journal of the American College of Cardiology (JACC) has identified differe...
US FDA approval for Abiomed’s Breethe OXY-1 system
The US Food and Drug Administration (FDA) has granted Abiomed a 510(k) clearance for an all-in-o...
Tricuspid annular dilatation predicts mortality in aortic stenosis patients undergoing TAVI
Tricuspid annular dilatation (TAD) is an independent predictor of all-cause mortality in patients wi...
ACC publishes consensus document on TAVI-related conduction disturbances
The American College of Cardiology (ACC) has published an expert consensus decision pathway on the m...
Research programme to probe causes of unexplained cardiac arrest
A research programme into understanding the underlying causes of unexplained cardiac arrest has rece...
Meta-analysis supports use of all-cause mortality in PCI versus CABG trials
A meta-analysis of 23 randomised clinical trials comparing percutaneous coronary intervention (P...
Raising the bar for competency in high-risk coronary procedures
Rhian E Davies (University of Washington Medical Center, Seattle, USA) discusses a recent paper ...
JACC journal series looks at impact of COVID-19 on cardiovascular health
The Journal of the American College of Cardiology (JACC) has issued a three-part focus seminar on CO...
OPTIMIZE IDE study of Svelte drug-eluting stent shared at TCT Connect 2020
Results of the OPTIMIZE IDE study, assessing the Svelte drug-eluting stent (DES) Integrated Delivery...
Biosensors gains CE mark approval for BioFreedom Ultra stent system
Biosensors has announced the award of a CE mark for BioFreedom Ultra drug-coated coronary stent syst...
TCT Connect 2020: CeloNova announces interim data from 14-day DAPT trial
CeloNova BioSciences has announced interim results from the randomised Trial of COBRA PzF Stenti...
TCT Connect 2020: Durable polymer DES non-inferior to biodegradable polymer stents in ACS patients
Results of the HOST-REDUCE-POLYTECH-ACS, presented at TCT Connect 2020 (14–18 October, virtual) ...
TCT Connect 2020: SOLVE-TAVI shows higher rate of stroke for balloon-expandable valve
One-year follow-up results of the randomised SOLVE-TAVI trial showed similar rates of all-cause deat...
TCT Connect 2020: Reduced mitral regurgitation achieved with next generation MitraClip
One-year clinical outcomes from the global EXPAND study, reporting on the use of the third generatio...
Cardiovascular News 59 – October 2020: US Edition
In this issue:
POPular TAVI prompts call for aspirin-only antiplatelet strategy post-TAVI
IV...
TCT Connect 2020: Disrupt CAD III meets safety and effectiveness endpoints
Shockwave Medical has announced that the coronary Investigational Device Exemption (IDE) study—Disru...
Cardiovascular News 59 – October 2020
In this issue:
POPular TAVI prompts call for aspirin-only antiplatelet strategy post-TAVI
IV...
TCT Connect 2020: Philips announces one-year results of DEFINE PCI
Royal Philips has announced one-year results of the DEFINE PCI study, presented at TCT Connect 2020 ...
TCT Connect 2020: XIENCE trials demonstrate non-inferiority of shorter-term DAPT regimens
A shorter course of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (P...
TCT Connect 2020: MITHRAS trial finds interventional iASD closure non-superior to conservative therapy
Interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral v...
TCT Connect 2020: REFLECT II trial assesses TriGuard 3 embolic protection device in TAVI patients
The REFLECT II randomised clinical trial evaluating the safety and efficacy of a cerebral embolic pr...
TCT Connect 2020: Acurate neo fails to meet non-inferiority compared to Evolut in SCOPE II trial
Findings of the SCOPE II clinical trial, which were presented during a late breaking trial sessi...
TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF
An interim analysis of the Restore EF Study, presented at TCT Connect 2020 (14–18 October, virtu...
High-risk surgery patients vulnerable to cardiovascular diseases
One in five high-risk patients undergoing major non-cardiac surgery will develop one or more heart c...
TCT Connect 2020: Results demonstrate safety and procedural success of orbital atherectomy system
Cardiovascular Systems has announced the presentation of results from a large retrospective obse...
TCT Connect 2020: Primary PCI is preferable in COVID-19 positive patients with ST-Elevation
Initial findings from the North American COVID-19 ST-Segment Elevation Myocardial Infarction (NA...
Medtronic agrees to invest in TMVr device development
Medtronic has today announced a partnership with The Foundry—a medical device company incubator—to i...
TCT Connect 2020: PCI of non-flow-limiting vulnerable plaques is safe and enlarges follow-up lumen area
A pilot randomised trial of percutaneous coronary intervention (PCI) of non-flow-limiting vulnerable...
Medtronic announces plans for head-to-head TAVI device study
Medtronic has today announced plans to launch a randomised, head-to-head study comparing two tra...
TCT Connect 2020: NuVera announces results from first-in-human study of ICE catheter
NuVera Medical has announced positive results from its first-in-human feasibility study, assessi...
Perceval sutureless valve data presented at EACTS 2020
LivaNova has announced new data from the Perceval Sutureless Implant Versus Standard-Aortic Valve Re...
More randomised trials needed in cardiothoracic surgery, says EACTS president
The president of the European Association For Cardiothoracic Surgeons (EACTS) has called upon ca...
EACTS 2020: surgeons told to be wary of “creeping” rise of TAVI
“We now live in a world of wires,” commented Tom C Nguyen (chief of cardiac surgery, McGovern Me...
ACC announces collaboration on trial of Butterfly ultrasound system
Butterfly Network and the American College of Cardiology (ACC) have announced a collaboration on a c...
Robotics and advanced imaging provide protection and precision in PCI
This article, part of an educational supplement sponsored by Siemens Healthineers, details the use...
Development of AF after CABG linked to higher risk of cerebrovascular accidents at 10 years
Patients with postoperative atrial fibrillation (AF) after coronary artery bypass graft (CABG) s...
First patient implanted with next-generation AngelMed Guardian system
AngelMed has announced the first implant of the next-generation AngelMed Guardian system as part of ...
ESC and EACTS to review left main coronary artery stenosis evidence
The European Society of Cardiology (ESC) and the European Association for Cardiothoracic Surgery...
Assessing non-obstructive coronary disease in the cath lab: A tailored approach to treat anginal symptoms
Javier Escaned (Hospital Universitario Clínico San Carlos, Madrid, Spain) discusses the increased in...
EXCEL analysis supports protocol definition of procedural myocardial infarction
An analysis of the rates and clinical implications of alternative definitions of procedural myocardi...
Medtronic’s Resolute Onyx approved for one-month DAPT labelling by US FDA
Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for ...
Study finds over 2,000 excess cardiovascular deaths in England and Wales during pandemic
Research has identified 2,085 excess deaths in England and Wales linked to cardiovascular disease du...
Cardiac Dimensions secures US$17.5 million series C financing
Cardiac Dimensions has closed a US$17.5 million series C financing round which will be used to a...
Boston Scientific launches Acurate neo2 aortic valve system in Europe
Boston Scientific has today announced it has initiated a controlled launch of the Acurate neo2 a...
InnovHeart announces first-in-human use of its Saturn mitral valve
InnovHeart has announced the successful first-in-human implantation of its proprietary Saturn transc...
Review looks at TAVI device selection and concludes head-to-head studies needed
Transcatheter aortic valve implantation (TAVI) device selection should be guided by patient, ana...
The challenges of the modern cath lab
Over the last decade, the cath lab has transformed. Interventional cardiologists are now not only tr...
V-Wave closes US$98 million financing round
V-Wave has closed a Series C financing extension of up to US$98 million, assuring capital to complet...
Breakthrough status for Medtronic’s Tyrx for use with ventricular assist devices
Medtronic has received Breakthrough Device Designation status from the US Food and Drug Administrati...
Recurrent heart attacks declining, but overall rate remains high
After surviving a heart attack, the proportion of patients who experience a repeat attack within...
Abbott receives CE mark for the next-generation Mitraclip
Abbott has today announced it has received CE mark approval for its fourth-generation MitraClip tran...
IVUS linked to favourable PCI outcomes, but uptake is low
A study of US Medicare patients undergoing percutaneous coronary intervention (PCI) has found th...
TCT Connect 2020 to feature late-breaking interventional cardiology studies
The Cardiovascular Research Foundation (CRF) has announced that over 30 late-breaking trial and scie...
J Dawn Abbott
J Dawn Abbott is the director of interventional cardiology and an associate professor of medicine in...
Aspirin-free monotherapy after coronary artery stenting is feasible and safe
Aspirin-free prasugrel monotherapy following successful everolimus-eluting stent implantation demons...
VitalConnect begins TELESTAR-TAVR remote monitoring study
VitalConnect has announced the commencement of the TELESTAR-TAVR clinical study—Deployment of Te...
AHA calls for awareness of medication-induced arrhythmias
Healthcare professionals should become more familiar with medications that cause arrhythmias, ac...
Cardiac MRI effective at identifying myocarditis in athletes
Cardiac magnetic resonance imaging (MRI) is effective in identifying inflammation of the heart m...
Older patients “unaware” of heart valve disease risks
Survey results published to mark Heart Valve Disease Awareness Week show that older Europeans are un...
A variety of tools are now available for physiological assessment
Multiple studies have shown that fractional flow reserve (FFR) is a valuable modality for assessing ...
TIDES-ACS confirms performance of Hexacath’s titanium-nitride-oxide coated stent
Results of the TIDES-ACS randomised controlled trial, confirming the superior safety and sustain...
Medtronic begins early feasibility study of the Intrepid transcatheter valve system
Medtronic has announced US Food and Drug Administration (FDA) approval of an early feasibility stud...
Patient-specific, 3D printed aortic valve model used in preparation for TAVR procedure
Researchers from the University of Minnesota, with support from Medtronic, have developed a process ...
Cardiac Dimensions receives Australian regulatory approval for its Carillon mitral contour system
Cardiac Dimensions has announced that Australia’s Therapeutic Goods Administration (TGA) has approve...
Fujifilm Sonosite receives FDA clearance for COVID-19 use of its cardiac ultrasound systems
Fujifilm Sonosite has received 510(k) clearance from the US Food & Drug Administration (FDA) for...
Japan and the USA see an increase in PCI procedures
Japan and the USA have seen an increase in percutaneous coronary intervention (PCI) procedures, whic...
First patient enrolled in TRANSFORM-1 study of MagicTouch DCB
Concept Medical has announced the enrolment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt o...
CryoLife acquires Ascyrus Medical
CryoLife has announced the acquisition of Ascyrus Medical, developer of the Ascyrus Medical Dissecti...
ACC announces revised dates for ACC.21
The American College of Cardiology (ACC) has announced that its 70th Annual Scientific Session, ACC....
BioVentrix resumes ALIVE trial after COVID-19 pause
BioVentrix has announced the resumption of cases in the pivotal ALIVE Trial studying Less Invasive V...
ESC 2020 Congress: ISCHEMIA trial suggests invasive approach benefits high risk patients
An invasive approach involving either percutaneous coronary intervention (PCI) or coronary arter...
ESC 2020 Congress: No discernible effect on saphenous vein graft patency from adding ticagrelor to aspirin after CABG
According to findings of the POPular CABG trial, the addition of ticagrelor to aspirin after cor...
Philips launches latest version of its Azurion imaging platform
Royal Philips has announced the next-generation of its Azurion image-guided therapy platform, de...
Miracor secures financing to support PiCSO clinical study
Miracor Medical has announced the closing of a €24 million series-E round of financing. The roun...
ESC 2020 Congress: AF associated with long-term mortality in primary PCI patients regardless of LV function
Atrial fibrillation (AF) is associated with long-term mortality in patients undergoing primary p...
ESC 2020 Congress: POPular TAVI findings point to aspirin-only antiplatelet strategy
The POPular TAVI trial has challenged current recommendations on antiplatelet treatment after tr...
ESC Congress 2020: Mavacamten improves heart function in HCM patients
Mavacamten (MyoKardia) improves heart function and symptoms in patients with obstructive hypertr...
ESC 2020 Congress: TMVR with Tendyne results in favourable LV remodelling
Transcatheter mitral valve replacement (TMVR) with the Tendyne device (Abbott) results in favourable...
ESC Congress 2020: Society publishes new guidelines on congenital heart disease, non-ST-segment elevation ACS
The European Society of Cardiology (ESC) has issued new guidelines, published online today in the Eu...
ESC 2020 Congress: EMPEROR-Reduced finds reduced mortality risk in HFrEF patients using empagliflozin
Empagliflozin reduces the risk of cardiovascular death or hospitalisation for heart failure in patie...
FDA approves revised labelling for Medtronic’s Evolut valve
Medtronic has announced that the US Food and Drug Administration (FDA) has approved revised comm...
Cardiovascular News 58 – August 2020
Meta analysis puts spotlight on optimal DAPT duration
Cardiologists warn of long-term impact ...
Cardiovascular News 58 – August 2020: US Edition
Meta analysis puts spotlight on optimal DAPT duration
Cardiologists warn of long-term impact ...
Make confident diagnostic decisions on coronary artery diseases – fast
In this educational supplement, sponsored by Siemens Healthineers, Cardiovascular News explores ...
Philips expands cardiovascular ultrasound portfolio with Affiniti CVx
Philips announced today the latest addition to its portfolio of dedicated cardiovascular ultrasound ...
AHA issues guidance on stroke prevention in heart surgery patients
Guidelines for reducing the risk of stroke in patients undergoing heart surgery have been detail...
Heart Rhythm Society publishes Cardiovascular Digital Health Journal
The Heart Rhythm Society has announced the publication of the inaugural issue of the Cardiovascular ...
Chinese study suggests STEMI patients had increased mortality risk during COVID-19 pandemic
The risk of in-hospital death and in-hospital heart failure increased for ST-elevation myocardial in...
Heart teams and interventional cardiologists often differ over recommendations for multivessel CAD
A study comparing recommendations from a heart team versus those of an interventional cardiologi...
Women “underrepresented” in heart failure studies
Representation of women leading heart failure research remains limited, according to a...
Transcatheter tricuspid valve replacement “low risk” for complications
Transcatheter tricuspid valve replacement in the setting of trans-tricuspid pacemaker leads with...
Philips introduces Omniwire for coronary artery procedures
Royal Philips has announced the introduction of OmniWire, a solid core pressure wire for coronary ar...
ESC 2020 Congress: Digital platform takes congress to a wider audience
Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking place from 29 August–1 S...
Cardiovascular risk factors linked to COVID-19 complications and death
COVID-19 patients with cardiovascular comorbidities or risk factors are more likely to develop cardi...
10-year data on VIVO ISAR drug-eluting stent published in JACC
Translumina has announced the publication of 10-year follow-up data on its dual-drug polymer-fre...
Digital learning is becoming a part of the “new normal”
With whole sections of society migrating online during the COVID-19 pandemic, e-learning has ris...
Stress may have clinical implications for heart failure patients
Mental stress and anger may have clinical implications for patients with heart failure according to ...
Biosensors announces enrolment of first patient in REFORM pivotal trial
Biosensors announced today the enrolment of the first patient in REFORM—a prospective, randomised, n...
Survey reveals patient attitudes to heart valve procedures
A US survey released by patient advocacy group Heart-Valve-Surgery.com, with support by Medtronic, h...
InnovHeart secures US$24 million finance package
InnovHeart—developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatmen...
JAHA retracts paper calling for end to cardiology diversity programmes
The Journal of the American Heart Association (JAHA) has retracted a paper published in March 2020, ...
FORWARD PRO study of Evolut Pro valve meets safety and efficacy goals
Thirty-day clinical outcomes from the FORWARD PRO international study of the Evolut Pro (Medtron...
CardioMech secures financing for mitral valve repair study
CardioMech, developer of a transfemoral, transseptally delivered mitral valve repair technology, ann...
Meta-analysis advocates “personalised approach” to DAPT duration after PCI
A meta-analysis of 24 randomised controlled trials assessing dual antiplatelet therapy (DAPT) af...
Eko and AstraZeneca announce digital cardiovascular health partnership
Eko has announced a collaboration with AstraZeneca to accelerate the development of digital health t...
FDA issues EUA for left-sided Impella to provide left ventricular unloading
The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for le...
Tailoring therapy and maximising TAVI programme efficiency
In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores the use...
Using remote learning to improve high-risk PCI outcomes
As interventional cardiology continues to grow with higher risk patients and more complex corona...
Frankfurt study finds high rate of cardiac complications in recovered COVID-19 patients
A German study of recently-recovered COVID-19 patients examined using magnetic resonance imaging (MR...
Japanese study finds high survival rates with use of Impella heart pump
A three-year, investigator-led, prospective study of Japanese patients who received an Impella h...
Low one-year rate of mortality found in mitral valve-in-valve replacement using Sapien 3
One-year outcomes of mitral valve-in-valve replacement using the Sapien 3 (Edwards Lifesciences)...
Keystone Heart announces first case using TriGUARD 3 CEP device
Keystone Heart has announced completion of the first worldwide commercial case using the TriGUAR...
NSAIDs increase bleeding risk after myocardial infarction, Korean study finds
Use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat first-time heart attack patients sign...
American College of Cardiology to launch JACC: Asia
The American College of Cardiology (ACC) is expanding its JACC family of peer-reviewed journals to i...
Abiomed gains approval for data streaming from the Impella console
The US Food and Drug Administration (FDA) has approved one-way digital data streaming during pat...
TAVI or surgical valve replacement “similarly effective” in men and women
Aortic valve replacement, using either transcatheter aortic valve implantation (TAVI) or surgica...
Caption Health gains FDA approval for updates to its cardiac AI system
Caption Health, a developer of medical artificial intelligence (AI) technology, has received US ...
Mavacamten granted Breakthrough Therapy Designation
MyoKardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Ther...
Funding secured to further study of AI systems for cardiovascular health
Digital health and artificial intelligence (AI) company Eko has been awarded a US$2.7 million Small ...
Genetic testing could aid decision-making in cardiovascular healthcare
Genetic testing and counselling for inherited cardiovascular diseases may help patients and thei...
Race and gender bias may impact the timing of treatment for heart failure patients
Findings of a US investigation of clinician race and gender bias in decision-making around heart...
Inspiron sirolimus eluting stent receives CE mark approval
Scitech has announced that the Inspiron coronary sirolimus eluting stent has received CE mark approv...
Next-generation Watchman LAAC device gains US FDA approval
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman F...
LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch
LifeSignals Group has announced that it has received US Food and Drug Administration (FDA) 510(k) cl...
LivaNova launches Perceval Plus sutureless heart valve in Europe
LivaNova has announced that the advanced Perceval Plus sutureless surgical aortic heart valve is now...
Women taking beta blockers for hypertension may have higher risk of heart failure with acute coronary syndrome
Women taking beta blockers for hypertension with no prior history of cardiovascular disease have a n...
Fall in hospitalisations for acute coronary syndrome seen during COVID-19
A rise in the number of out-of-hospital cardiac arrests (OHCAs) correlated with a fall in the number...
FDA approval for Edwards Lifesciences’ KONECT RESILIA aortic valved conduit
Edwards Lifesciences has announced approval from the US Food and Drug Administration (FDA) for t...
AHA Scientific Sessions 2020 to be held virtually
The American Heart Association (AHA) has announced that its 2020 Scientific Sessions will be present...
Half of COVID-19 patients receiving echocardiograms show heart abnormalities
Around half of COVID-19 patients who received an echocardiogram in-hospital showed abnormalities in ...
FDA grants Breakthrough Device Designation for Doraya temporary catheter
Revamp Medical has announced that the US Food and Drug Administration (FDA) has granted Breakthrough...
ACIST Medical Systems announces launch of Navvus II Rapid Exchange FFR microcatheter
ACIST Medical Systems has announced the global launch of its ACIST Navvus II Rapid Exchange FFR Micr...
Venus Medtech and Pi-Cardia to bring Leaflex catheter to Chinese market
Venus Medtech has announced a collaboration to bring Pi-Cardia's Leaflex technology to China.
...
Carag Bioresorbable Septal Occluder approved for US IDE trial
US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval has been g...
PCR e-Course 2020: Roll-in trial finds high device success rate for Amplatzer Amulet occlusion device
Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high imp...
PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, ma...
Smartphone app uses can identify lung congestion in heart failure patients
Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing ...
Philips gains FDA clearance for the use of its ultrasound portfolio to manage COVID-19 cardiac complications
Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Admi...
FDA approves update to cardiac imaging system to aid COVID-19 diagnostics
The US Food and Drug Administration (FDA) has expedited clearance of an update to software from ...
Boston Scientific announces positive PINNACLE FLX study results
Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial a...
LifeSignals receives CE mark for the ECG Remote Monitoring Patch
LifeSignals has received CE mark approval for the LifeSignals ECG Remote Monitoring Patch, a dis...
iRhythm offers home enrolment of Zio monitoring devices
iRhythm Technologies has announced a virtual platform to support patients and clinicians in the ...
US heart societies express concern over using hydroxychloroquine and azithromycin for COVID-19
Presidents of leading cardiac organisations, including the American Heart Association (AHA), the Ame...
Webinar: Cardiovascular specialists detail COVID-19 strategies
Cardiovascular specialists from across the globe shared current knowledge and key experience of ...
AHA issues oxygenation and ventilation guidance for healthcare providers
The American Heart Association (AHA), in conjunction with the American Association for Respirato...
Athena Poppas begins ACC presidency
Athena Poppas (Providence, USA) is the new president of the American College of Cardiology (ACC)...
Cardiologists share COVID-19 insights
Cardiologists from across Europe have shared their experience of having treated COVID-19 patients, i...
Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardi...
Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study
Medtronic today announced positive results of the Onyx ONE Clear Study that evaluated the Resolu...
Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis patients
Transcatheter aortic valve implantation (TAVI) procedures had a high rate of success and low ris...
AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research
The American Heart Association (AHA) has committed US$2.5 million to research efforts to better unde...
Append Medical share clinical proof-of-concept results for internal sealing of LAA
Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device ...
VitalConnect adds arrhythmia detection to its remote monitoring software
VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring por...
AI-guided cardiac imaging system given FDA authorisation
The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acqu...
First patient enrolled in PREDICT-LAA clinical trial
FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA ...
ACC makes senior staff appointments
The American College of Cardiology (ACC) has announced several promotions and structural changes wit...
FDA grants Breakthrough designation for ECG-based algorithm
The US Food and Drug Administration has granted Breakthrough Device designation to the digital h...
European trial data ‘reinforce’ safety profile and efficacy of Lixiana
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial ...
AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor
Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor Sy...
Left atrial appendage closure associated with a decreased stroke risk in AF patients
Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk o...
Alain Cribier
Professor Alain Cribier is a pioneer in the field of aortic and mitral valvuloplasty and has been re...
